This web site was copied prior to January 20, 2005. It is now a Federal record managed by the National Archives and Records Administration. External links, forms, and search boxes may not function within this collection. Learn more.   [hide]

NIH Clinical Research Studies Listed By Protocol Number


Active Accrual, Protocols Recruiting New Patients 
* 05-N-0001:
Propranolol for Syncope with Sympathoadrenal Imbalance in Children

* 05-CC-0003:
A Pilot Study to Detect the Effect of Sildenafil Citrate on Cerebral Blood Perfusion in Multiple Sclerosis Patients by Perfusion MRI

* 04-NR-0069:
Evaluation of Efficacy and Mechanisms of Topical Thalidomide for Chronic Graft-Versus-Host-Disease Related Stomatitis

* 04-N-0287:
Efficacy of Rituximab in Patients with Stiff Person Syndrome with Anti-GAD Antibodies: A Randomized Placebo-Controlled Trial

* 04-N-0278:
Neural Correlates of Observation of Tactile Stimulation in Healthy Subjects

* 04-N-0258:
Transcutaneous Lisuride Therapy for Parkinson's Disease

* 04-N-0244:
A Phase III Multicenter Study of Intratumoral/Interstitial Therapy with TransMID Compared to Best Standard of Care in Patients with Progressive and/or Recurrent, Non-Resectable Glioblastoma Multiforme

* 04-N-0243:
Glycogen Synthetase Kinase 3 (GSK-3) Inhibition in Alzheimer's Disease

* 04-N-0236:
Investigation of Biomarkers in Parkinson's Disease

* 04-N-0225:
5HT2A/C Serotonin Blockade in Parkinson's Disease

* 04-N-0220:
Measuring the Brain Effects of DC Polarization with O-15 PET

* 04-N-0212:
Enhancement of Rehabilitative Treatment-Dependent Functional Recovery After Stroke by Transcranial Direct Current Stimulation (tDCS)

* 04-N-0210:
Towards the Establishment of Standards of Practice and the Initiation of Multi-Center, Multi-National Clinical Trials for Neonates and Children With Stroke

* 04-N-0209:
Human Herpesvirus-6 and Its Effect on the GABA/glutamate Balance in the Cerebrospinal Fluid and in the Brain from Patients with Epilepsy

* 04-N-0207:
An Open Label Clinical Trial of Replagal Enzyme Replacement Therapy In Children With Fabry Disease Who Have Completed Study TKT023

* 04-N-0203:
Neural Correlates of Observational Motor Learning in Chronic Stroke Patients

* 04-N-0192:
The Role of the Prefrontal Cortex in Economic Decision-Making in Reciprocal Trust Games Using Functional Hyperscanning Neuroimaging

* 04-N-0188:
Neurophysiological Markers in Patients with Craniofacial Dystonia and Their Relatives

* 04-N-0159:
Functional MRI (fMRI) and Diffusion Tensor Imaging (DTI) in Temporal Lobe Epilepsy

* 04-N-0156:
Central Motor Physiology in Polio Survivors

* 04-N-0153:
Timing of Voluntary Movement in Patients With Tourette Syndrome and Chronic Tic Disorder Using EEG and Surface EMG

* 04-N-0151:
Timing of Voluntary Movement in Patients with Schizophrenia Using EEG and Surface EMG

* 04-N-0147:
Treatment Efficacy of 1-Octanol Compared to Placebo in Adults with Essential Tremor

* 04-N-0146:
fMRI Study on Mechanism of Rhythm Perception and Generation

* 04-N-0133:
Effects of a T Cell-Depleting Monoclonal Antibody, Alemtuzumab, in Patients with Inclusion Body Myositis: A Pilot Clinicopathological Study

* 04-N-0129:
Phase 1B Clinical Trial to Establish the Safety and Tolerability of a Multiple-Dose Regimen of Idebenone Administered to Patients With Friedreich's Ataxia

* 04-N-0122:
Direct Current Brain Polarization in Frontotemporal Dementia

* 04-N-0117:
Modulation of the Visual Information Processing in the Human Parieto-Frontal Network as Studied by a Frequency Tagging Technique During Visuomotor Tracking

* 04-N-0113:
Examining Associative Relations in Structured Event Complexes Using Functional Neuroimaging

* 04-N-0110:
Enhanced Tactile Memory in the Blind

* 04-N-0107:
Motor Skill Learning: Spinal Reflexes

* 04-N-0103:
Changes in Intracortical Inhibitory Processes are Associated With the Development of Implicit Learning of a Motor Task

* 04-N-0101:
Levetiracetam Treatment of L-dopa Induced Dyskinesias

* 04-N-0100:
Role of the Right Hemisphere in Recovery of Language Function in Chronic Stroke

* 04-N-0098:
Brain Reorganization in Cerebral Palsy

* 04-N-0073:
A Phase I-II Pharmacokinetic/Pharmacodynamic Study of Replagal to Assess the Effects of Alternative Dose and Regimen in Patients with Fabry Disease

* 04-N-0066:
A Prospective, Randomized Trial Comparing Surgery Versus Radiosurgery for the Treatment of Metastatic Brain Tumors

* 04-N-0059:
Sensorimotor Gating Studies in Restless Legs Syndrome

* 04-N-0054:
Intraspinal Plasticity Associated with Locomotor Learning

* 04-N-0042:
Improvement of Use Dependent Plasticity in Chronic Stroke Patients

* 04-N-0041:
The Physiology of Tricks

* 04-N-0034:
Classification of Cerebral Palsy Subtypes

* 04-N-0033:
MRI in Autosomal Dominant Partial Epilepsy with Auditory Features

* 04-N-0029:
A Clinical Trial of Replagal Enzyme Replacement Therapy in Children Ages 7 - 17 Years with Fabry Disease

* 04-N-0019:
Zenapax (daclizumab) Administered to Patients with Multiple Sclerosis (ZAP MS): Effect of Intravenously Administered Humanized Monoclonal Antibody Against the Interleukin-2 Receptor Alpha Subunit (Daclizumab) on Inflammatory Activity in the Central Nerv

* 04-N-0017:
Movement Related Cortical Potentials in Primary Lateral Sclerosis

* 04-N-0016:
Non-Invasive Seizure Localization in Patients with Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings

* 04-N-0015:
Activating Effects of Sleep Deprivation On Synchronized MEG-EEG Recordings Of Epilepsy Patients with Non-Diagnostic EEG

* 04-N-0005:
Analysis of Brain Metastasis in Patients with Breast Cancer, with and without Over-Expression of HER-2

* 04-M-0270:
Investigating the Role of Serotonin in Emotional Processing Through the Use of Tryptophan Depletion

* 04-M-0247:
Treatment Study for Frontotemporal Dementia

* 04-M-0227:
Combining a Dopamine Agonist and Selective Serotonin Reuptake Inhibitor for Treatment of Depression: A Double-Blind, Randomized Study

* 04-M-0222:
Investigation of the Rapid (Next Day) Antidepressant Effects of an NMDA Antagonist

* 04-M-0221:
The Treatment of Menstrually-Related Mood Disorders with Extended Versus Interrupted Oral Contraceptives

* 04-M-0208:
PET Evaluation of Serotonin Transporters Using [C-11] DASB in Alcoholism

* 04-M-0204:
PET Whole Body Biodistribution and Test Retest Brain Imaging Studies Using a Dopamine Transporter Ligand [18F]FECNT

* 04-M-0189:
Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors with [18F] SPA-RQ

* 04-M-0183:
Association Between Adenosine Receptor Gene Polymorphisms and Phsyiological Responses to Caffeine in Subjects with Panic Disorder and Healthy Controls

* 04-M-0180:
PET Evaluation of Monoamine Transporters in Obsessive-Compulsive-Related Disorders

* 04-M-0170:
Whole Body Study of [11C]NNC-112 PET Imaging of Dopamine D1 Receptors

* 04-M-0160:
Neural Correlates of Depressive Symptoms and Reward Related Mechanisms Following AMPT Depletion in Remitted Depressed Patients Off Treatment and Healthy Controls

* 04-M-0139:
The Effects of Dutasteride on Mood, HPA Axis, and Serum Allopregnanolone Levels in Women with Menstrual-Related Mood Disorders and Controls

* 04-M-0136:
Neurocardiac Control in Major Depression

* 04-M-0091:
An Investigation of a Pharmacologic Strategy to Bring About Rapid (Next Day) Antidepressant Effects

* 04-M-0075:
FMRI Study of Performance During a Probabilistic Reversal Learning Task in Depression

* 04-M-0002:
The Functional Neuroanatomy of Emotion Regulation in Major Depressive Disorder (MDD)

* 04-I-0289:
Secondary Transplantation Using Moderate Dose Busulfan as Conditioning for a Patient with Partial Reconstitution Post Initial Allogeneic Transplantation

* 04-I-0286:
A Longitudinal Study of Familial Hyperosinophilia (FE): Natural History and Markers of Disease Progression

* 04-I-0266:
Collection of Peripheral Blood and Bone Marrow From Healthy Donors for Use in In Vitro Research

* 04-I-0254:
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a 6-Plasmid Multiclade HIV-1 DNA Vaccine, VRC-HIVDNA016-00-VP, in Uninfected Adult Volunteers

* 04-I-0231:
Procurement of Clinical Specimens for Immunologic or Genetic Studies in Inflammatory Bowel Diseases

* 04-I-0187:
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Twice-Weekly Peginterferon Alpha 2a and Ribavirin Induction Therapy for Chronic Hepatitis C in Patients who are Coinfected with HIV-1

* 04-I-0176:
Pilot Study of Omalizumab in Eosinophilic Gastroenteritis

* 04-I-0172:
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Recombinant Multiclade HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Adult Volunteers

* 04-I-0158:
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase III Study to Evaluate Corticosteroid-Reduction and -Sparing Effects of Mepolizumab 750 mg Intravenous in Subjects with Hypereosinophilic Syndromes (HES), and to evaluate th

* 04-I-0149:
An Open Label Trial to Assess Safety and Tolerability of Daclizumab in HIV-Infected Individuals

* 04-I-0126:
Exhaled Breath Condensate as a Measurement of Airway Inflammation in Children with Asthma

* 04-I-0097:
A Randomized Controlled Study to Evaluate the Safety and Efficacy of Long-Term Peginterferon Alpha 2a for Treatment of Chronic Hepatitis C Patients Coinfected with HIV-1

* 04-I-0087:
A Phase II, Double-Blind RAndomized, Placebo-Controlled Study to Evaluate the Antiviral Activity, Safety, Tolerability, and Pharmacokinetics of GW873130 for 10 Days in HIV-1 Infected Adults

* 04-I-0086:
Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research on HCV-Infected Patients

* 04-I-0030:
Evaluation and Management of Persons with Severe Acute Respiratory Syndrome (SARS)

* 04-I-0022:
An Open Label Pilot Study Examining the Use of Rituximab in Patients with Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies

* 04-I-0018:
Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Anti-Retroviral Treatment in HIV Infected Patients with CD4 T-Lymphocyte Count Greater Than 500 Cells/mm(3) Who Have Received Anti-Retroviral

* 04-HG-0226:
Investigations of Megakaryocytes from Patients with Abnormal Platelet Vesicles

* 04-HG-0127:
Clinical and Basic Investigations of Methylmalonic Acidemia (MMA)

* 04-HG-0123:
Bardet-Biedl Syndrome: Phenotype and Metabolic Characteristics

* 04-HG-0093:
Clinical and Genetic Studies on Holoprosencephaly

* 04-HG-0092:
Bioenergetic Function in Parkinson's Disease

* 04-H-0268:
Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients with Coronary Artery Disease

* 04-H-0213:
Cytokine Gene Polymorphisms in Bone Marrow Failure

* 04-H-0211:
Specimen Procurement From Individuals With Hereditary Pulmonary Fibrosis

* 04-H-0202:
Human Diseases with Mutation of Non-muscle Myosin Heavy Chain Genes

* 04-H-0179:
Peripheral Blood Hematopoietic Progenitor Cell Mobilization Using Granulocyte Colony Stimulating Factor (G-CSF) Combined With AMD3100 in Healthy Volunteers

* 04-H-0143:
Modulation of Vascular Endothelial Growth Factor (VEGF) Using an Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication

* 04-H-0112:
Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Effect of Peritransplant Cyclosporine on Chimerism

* 04-H-0090:
A Pilot Study of the Safety and Efficacy of Imatinib in Reducing Monocytosis or Leukocytosis in Patients with Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia, Respectively

* 04-H-0082:
Technical Development of Strain Rate Echocardiography

* 04-H-0078:
Peripheral Blood Hematopoietic Progenitor Cell Mobilization with AMD3100 in Healthy Volunteers Previously Mobilized with G-CSF

* 04-H-0062:
The Role of Atrio-Ventricular Coupling in Exercise Tolerance in Non-Obstructive Hypertrophic Cardiomyopathy

* 04-H-0026:
A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)

* 04-H-0012:
Collection of Blood, Bone Marrow, Urine, and/or Tissue Samples from Patients with Solid Tumors, Hematological Malignancies or Non-Malignant Hematologic Disorders or HLA Compatible Family Members

* 04-EI-0260:
Use of Immune Cell Markers, Cytokines, and Transcription Factors as Markers of Intraocular Inflammatory Activity

* 04-EI-0241:
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects with Anterior Segment Disease

* 04-EI-0240:
Pilot Study of Intravitreal Injection of Ranibizumab (rhuFAB V2) for Advanced Ocular Disease of Von Hippel-Lindau Disease

* 04-EI-0190:
Pilot Study of Helicobacter Pylori and Ocular Surface Disease

* 04-EI-0166:
A Cross Sectional Clinical Study of Human Lens Aging and Cataract Formation, in Vivo, Using Dynamic Light Scattering (DLS)

* 04-EI-0157:
Evaluation and Treatment of Ocular Complications of Vaccinia Vaccination: Suitability of NP-016 Vaccinia Immune Globulin (VIG) for Sight-Threatening Conditions [VIG31]

* 04-EI-0128:
Evaluation of the Age-Related Eye Disease Study (AREDS) Clinical Lens Grading System

* 04-EI-0115:
Combination Daclizumab/Sirolimus Therapy For the Induction of Immune Tolerance in Non-Infectious Intermediate and Posterior Uveitis

* 04-EI-0065:
Evaluation of Infliximab in the Treatment of Non-Infectious Scleritis

* 04-EI-0048:
Digital Image Based Determination of Ocular Surface Vital Dye Staining

* 04-EI-0039:
Evaluation and Treatment of Pediatric, Developmental and Genetic Eye Disease

* 04-EI-0006:
Daclizumab for Active, Non-infectious, Sight-threatening Uveitis: A Phase II Pilot Study

* 04-DK-0193:
Identification and Mechanistic Investigations of Tolerant Kidney Transplant Patients

* 04-DK-0161:
Studies of the Natural History of Sickle Cell Disease and Other Hemolytic Disorders

* 04-DK-0140:
The Effects of Thyroid Hormone on Cytochrome P450 and P-Glycoprotein Activity in Thyroid Cancer Patients

* 04-DK-0099:
Depletional Induction with Rabbit Anti-Thymocyte Globulin, Followed by Two Approaches Toward Monotherapy Immunosuppression in Kidney Transplant Recipients

* 04-DK-0061:
Free Fatty Acid Flux in African Americans

* 04-DK-0057:
Renal Transplantation in Recipients with Nephropathic Cystinosis

* 04-DK-0021:
Urinary Vitamin C Loss in Diabetics

* 04-D-0267:
Clinical Research Core Dental Screening Protocol

* 04-D-0248:
Evaluation of Vanilloid Receptor Inactivation for Preemptive Analgesia

* 04-D-0182:
Bradykinin-1 Receptor and Kinin Induction in a Clinical Model of Tissue Injury

* 04-D-0125:
Imaging Neural Mechanisms Underlying Pain Modulation

* 04-D-0124:
Proinflammatory Gene Expression and Prostanoid Levels in a Clinical Model of Tissue Injury

* 04-D-0111:
The Effects of Viscosupplementation Using Synvisc in Symptomatic Osteoarthritis of the Temporomandibular Joint

* 04-CH-0250:
Event Related Potentials in Infants and Adults

* 04-CH-0056:
The Neural Immune Mechanisms and Genetic Influences on Chronic Pelvic Pain in Women with Endometriosis

* 04-CH-0010:
The Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control Study

* 04-CC-0237:
The Effects of Respiratory Motion on CT Based Attenuation Correction of Positron Emission Tomography Data: Liver and Heart Studies

* 04-CC-0194:
Utility of Isoproterenol Challenge Test to Detect Disease in Patients with Incomplete Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy

* 04-CC-0178:
The Treatment of Deep Vein Thrombosis of the Lower Extremities with "Low-Dose" Alteplase: a Pilot Study

* 04-CC-0130:
The Effect of a Systemic Oral Care Program on Reducing Exposure to Oropharyngeal Pathogens in Critically III Patients

* 04-CC-0119:
Biomarkers and Protein Mass Expression Profiles in Bronchoalveolar Lavage from Patients with Lung Infiltrates

* 04-CC-0118:
Assessment of the Natural History and Peptide Immunization-Induced Immunological Response in Patients at High Risk for Recurrence of Anaplastic Nasopharyngeal Cancer

* 04-CC-0109:
Comprehensive Prostate MRI for the Evaluation of Prostate Cancer at 3:OT: A Pilot Study

* 04-CC-0085:
The Effect of Lopinavir/Ritonavir on Endothelial Function in Normal Volunteers

* 04-CC-0070:
Exploring Patient-Provider Trust Among Individuals with End-Stage Renal Disease

* 04-CC-0046:
Citrate Effects and Bone Density Studies in Long-Term Apheresis Donors

* 04-CC-0040:
Prednisolone Pharmacokinetics in the Presence and Absence of Ritonavir after Oral Prednisolone Administration to Healthy Volunteers

* 04-CC-0032:
Atorvastatin Therapy To Improve Endothelial Function in Sickle Cell Disease

* 04-CC-0007:
Comprehensive Epitope Mapping of the Epstein-Barr Virus Latent Membrane Protein-2 in Ethnically Diverse Populations

* 04-C-0288:
Treatment of Patients with Metastatic Melanoma Using a Transplant of Autologous Lymphocytes Reactive with Tumor Following a Meyloablative Lymphocyte Depleting Regimen of Chemotherapy, Total Body Irradiation and Reconstitution with CD34+ Cells

* 04-C-0281:
Prospective Assessment of Clinical and Biological Factors Determining Outcomes in Patients with Chronic Graft-Versus-Host Disease

* 04-C-0280:
Randomized, Crossover, Pharmacokinetic Study of Paclitaxel (Taxol) and ABI-007 (a Cremophor EL-Free, Protein Stabilized, Nanoparticle Paclitaxel) in Patients with Advanced Solid Tumors

* 04-C-0277:
Treatment of Patients with Metastatic Renal Cell Cancer Using Cultured Tumor-Reactive Lymphocytes and Interleukin-2

* 04-C-0276:
A Pilot Study of a Three Month Intervention for Increasing Physical Activity in Sedentary Women at Risk for Breast Cancer

* 04-C-0275:
Targeted Oncolytic Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman's Disease with Laboratory and Clinical Correlates of Disease Activity

* 04-C-0273:
A Phase II Study of Hepatic Arterial Infusion of Melphalan with Venous Filtration via Peripheral Hepatic Perfusion (PHP) for Unresectable Primary and Metastatic Cancers of the Liver

* 04-C-0263:
A Phase I Dose Escalation Study of Heat Activated Liposome Delivery of Doxorubicin and Radiofrequency Ablation of Primary and Metastatic Tumors of the Liver

* 04-C-0262:
A Phase II Trial of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer

* 04-C-0259:
Immunization of Patients with Renal Cancer Using HLA-A2 and HLA-A3-Binding Peptides from Fibroblast Growth Factors 5 (FGF-5)

* 04-C-0257:
A Phase II Trial of Docetaxel, Thalidomide, Prednisone and Bevacizumab in Patients with Androgen-Independent Prostate Cancer

* 04-C-0256:
A Phase I Study of Single Agent OSI-774 (Tarceva) Followed by OSI-774 with Temozolomide for Patients with Selected Recurrent/Refractory Solid Tumors, Including Brain Tumors

* 04-C-0252:
A Pilot Trial of a CEA/TRICOM-Based Vaccine in Combination with Combined Chemotherapy/Radiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)

* 04-C-0251:
Treatment of Patients with Metastatic Melanoma by Lymphodepleting Conditioning Followed by Infusion of Anti-MART-1 TCR-Gene Engineered Lymphocytes and Subsequent Peptide Immunization

* 04-C-0246:
An Open Label Pilot Study to Evaluate the Safety and Tolerability of PANVAC-V (Vaccinia) and PANVAC-F (Fowlpox) in Combination with Sargramostim in Patients with Metastatic Adenocarcinoma

* 04-C-0238:
A Phase 2 Study of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Von Hippel Lindau Disease and Renal Tumors

* 04-C-0235:
A Study of Subcutaneous "Cyt 99 007" (Interleukin-7) in Conjunction with Peptide Immunization in Patients with Metastatic Melanoma

* 04-C-0234:
Tenofovir Disoproxil Fumarate Salvage Therapy in HIV-Infected Children and a Study of its Effect on Bone Metabolism

* 04-C-0232:
A Multi-Institutional Study of Proteomic Evaluation of Epithelial Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer Patients in First Clinical Remission: Development of a Protein Fingerprint Profile of Relapse

* 04-C-0229:
A Phase II Trial of Isolated Hepatic Perfusion (IHP) with Melphalan for Subjects with Metastatic Unresectable Colorectal Cancers of the Liver with Disease Refractory to First Line Systemic Chemotherapy

* 04-C-0218:
A Phase I Study of 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) with Evaluation of HSP-90 Client Proteins in Patients with Solid Tumors and Lymphomas

* 04-C-0200:
Urinary and Serum VEGF and MMP Levels in Patients Receiving Radiation Therapy for Glioblastoma Multiforme: Prospective Determination of a Predictive Value for Recurrence

* 04-C-0199:
Procurement of Normal Breast Tissue and Metastatic Breast Cancer Tissue for Molecular Profiling

* 04-C-0181:
Treatment of Patients with Metastatic Melanoma by Lymphodepleting Conditioning Followed by Infusion of TCR-Gene Engineered Lymphocytes and Subsequent Peptide Immunization

* 04-C-0177:
A Pilot Study of Tc-94m Sestamibi PET MDR Imaging

* 04-C-0173:
Phase II Study of UCN-01 in Relapsed or Refractory Systemic Anaplastic Large Cell and Mature T-Cell Lymphomas

* 04-C-0171:
A Prospective Histopathologic Study of Dynamic Contrast Enhanced MRI for Prostate Cancer Delineation and Characterization with the APT-MRI System

* 04-C-0168:
Pediatric Phase I Trial of LMB-2 for Refractory CD25-Positive Leukemias and Lymphomas

* 04-C-0167:
A Phase I Trial of a CEA-TRICOM Based Vaccine and Radiation to Liver Metastasis with or without Celecoxib in Patients with CEA Positive Solid Tumors

* 04-C-0152:
Treatment of Patients with Metastatic Melanoma Using Lymphocytes Reactive with the gp100 Antigen and Immunization Using a Recombinant rF-gp100P209 Virus Encoding a gp100 Peptide Following a Nonmyeloablative Lymphocyte Depleting Regimen

* 04-C-0148:
A Phase I Trial of Bevacizumab in Refractory Solid Tumors

* 04-C-0142:
A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Cutaneous T-Cell Lymphomas

* 04-C-0141:
Phase I Dose Escalation Study of the EGFR Tyrosine Kinase Inhibitor Gefitinib

* 04-C-0134:
Phase II Evaluation of Denileukin Diftotox in Patients with Metastatic Melanoma or Metastatic Kidney Cancer

* 04-C-0132:
A Phase II Trial Combining Estramustine, Docetaxel and Thalidomide in Patients with Androgen-Independent Metastatic Prostate Cancer

* 04-C-0131:
Allogeneic Breast Protocol 2: Phase I Trial of T cell Exchange with Th2/Tc2 Cells for Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning for Metastatic Breast Cancer

* 04-C-0121:
A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Chronic Lymphocytic Leukemia

* 04-C-0120:
Transcriptional Profiling of the Epidermal Response to Solar-Simulated Ultraviolet Radiation

* 04-C-0116:
T-Cell Depleted, Reduced-Intensity Allogeneic Stem Cell Transplantation from Haploidentical Related Donors for Hematologic Malignancies (HAPLO Part A)

* 04-C-0114:
Efficacy of Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling to Detect Axillary Lymph Node Metastases After Neoadjuvant Chemotherapy For Breast Cancer

* 04-C-0104:
Treatment of Patients With Metastatic Melanoma Using a Nonmyeloablative but Lymphocyte Depleting Regimen Followed by the Administration of In Vitro Sensitized Lymphocytes Reaction With ESO-1 Antigen

* 04-C-0095:
A Pilot Study of Intensified Lymphodepletion Followed by Autologous Hematopoietic Stem Cell Transplantation in Patients with Severe Systemic Lupus Erythematosus

* 04-C-0084:
A Pilot Study to Evaluate the Influence of Garlic on the Pharmacokinetics of Docetaxel in Patients with Metastatic Breast Cancer

* 04-C-0083:
A Study of Intra-Patient Escalating Doses of MDX-010 Given Alone or in Combination with Two gp100 Peptides Emulsified with Montanide ISA-51 in the Treatment of Patients with Stage IV Melanoma

* 04-C-0081:
Pathogenesis and Course of Cutaneous T-Cell Lymphoma

* 04-C-0080:
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults with Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

* 04-C-0079:
Pediatric Phase I Trial of BL22 for Refractory CD22-Positive Leukemias and Lymphomas

* 04-C-0055:
Randomized Study of Sirolimus (Rapamycin) Generated Donor Th2 Cells and In Vivo Sirolimus for GVHD Prevention after Allogeneic HSCT for Hematologic Malignancy

* 04-C-0051:
Evaluation of Angiogenesis Parameters and Tumor Markers in Inflammatory Breast Cancer Specimens

* 04-C-0049:
A Phase I/II Study of an Antitumor Vaccination Using Alpha (1,3) Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients With Refractory or Recurrent Non-Small Cell Lung Cancer

* 04-C-0044:
A Trial of Exemestane Alone or in Combination with Celecoxib in Postmenopausal Women at High Risk for Invasive Breast Cancer

* 04-C-0035:
A Phase I Trial of CC8490 for the Treatment of Patients with Recurrent/Refractory High-Grade Gliomas

* 04-C-0031:
Phase I Trial of Medi-507 in CD2-Positive Lymphoproliferative Disease

* 04-C-0014:
Phase II Trial of BL22 Immunotoxin in Hairy Cell Leukemia

* 04-C-0011:
A Study of Combination Chemotherapy & Surgical Resection in the Tx of Adrenocortical Cancer: Mitotane & Continuous Infusion Doxorubicin, Vincristine & Etoposide w/the P-glycoprotein Antagonist, Tariquidar (XR9576), Before & After Surgical Resection

* 04-C-0001:
Phase II Study of Sequential Gemcitabine Followed by Docetaxel for Recurrent Ewing's Sarcoma, Osteosarcoma, and Unresectable Sarcoma

* 04-AT-0239:
Effects of Osteoarthritis Pain, Morphine and Placebo on Neuro-Endocrine Function in Men

* 04-AR-0205:
Progression of Spinal Fusion in Ankylosing Spondylitis

* 04-AA-0072:
Clinical Trial of the Cannabinoid CB1 Receptor Antagonist, SR141716 (Rimonabant), to Reduce Voluntary Ethanol Drinking in Healthy, Non-Treatment Seeking Individuals Who Consume Between 20 and 40 Drinks Per Week

* 04-AA-0060:
The Effect of Ethanol on Cerebral Blood Flow as Measured by Functional Magnetic Resonance Imaging and the Development of Conditioned Response to Ethanol Administration

* 04-AA-0058:
Positron Emission Tomography Imaging of Incorporation of Docosahexaenoic Acid (DHA) from Plasma into Brain in Healthy Volunteers

* 03-N-0276:
Modafinil In the Treatment of Fatigue in Post-Polio Syndrome

* 03-N-0273:
Bi-hemispheric Plasticity Elicited By Unilateral Finger Motor Training

* 03-N-0272:
Cooling of the Head and Neck to Reduce Seizure Frequency: A Pilot Study

* 03-N-0267:
Improvement of Motor Learning in Chronic Stroke Patients By Transcranial DC Stimulation

* 03-N-0266:
Dopamine Release in Use-Dependent Plasticity in Health and Disease

* 03-N-0260:
Functional Brain Mapping of Laryngeal Sensorimotor Control in Voice Disorders

* 03-N-0236:
A Neuroimaging Study of Automatic Movements in Patients with Parkinson's Disease

* 03-N-0231:
Noninvasive Stimulation of Human Deep Brain Regions With a Magnetic Stimulator

* 03-N-0230:
Event-Related fMRI Analysis of Patients with Ideomotor Apraxia During Transitive and Intransitive Hand Gesturing

* 03-N-0224:
Remote Effects of Stroke on Cerebral Metabolism. Evaluation with Positron Emission Tomography and Proton Magnetic Resonance Spectroscopy

* 03-N-0220:
Safety Study of the Super Rapid Transcranial Magnetic Stimulation in Patients with Parkinson's Disease

* 03-N-0203:
SMN Levels in Peripheral Blood Samples of SMA Patients and the Effects of Pharmacological Compounds In Vitro

* 03-N-0197:
Reasoning About Social and Economic Knowledge: Identifying the Role of the Human Prefrontal Cortex Using Functional Neuroimaging

* 03-N-0196:
Social Knowledge Representation in the Human Prefrontal Cortex

* 03-N-0195:
Functional Neuroimaging of Social Cognitive and Emotional Processing: Technical and Cognitive Issues

* 03-N-0183:
Self-Perception of Postural Stability: Event-Related fMRI Study

* 03-N-0178:
Functional Neuroimaging of Calculus Problem Solving

* 03-N-0171:
Reperfusion of Stroke Safety Study Imaging Evaluation-2 (ROSIE 2) Adjunctive Treatment to Standard Alteplase Therapy of Ischemic Stroke

* 03-N-0165:
Cortical Control of Postural Stability in the Elderly

* 03-N-0164:
Evaluation and Treatment of Neurosurgical Disorders

* 03-N-0163:
Cross-Modal Plasticity of Verbal Memory in the Blind

* 03-N-0160:
EGF Polymorphisms and Gliomagenesis

* 03-N-0147:
Effects of AMPA Receptor Blockade on Human Cortical Excitability - A Pilot Study

* 03-N-0142:
Development of 7 Tesla MRI Methodology for Anatomical Functional and Spectroscopic Imaging of the Brain

* 03-N-0135:
Improved Function in the Paretic Hand of Chronic Stroke Patients by Transient Deafferentation of the Intact Upper Extremity

* 03-N-0134:
Neurophysiological Studies in Patients With Paroxysmal Hyperkinetic Movement Disorders

* 03-N-0126:
Spatiotemporal Dynamics of Cortical Connectivity Involved in Tics and Voluntary Movements in Patients With Tourette's Syndrome and Chronic Motor Tic Disorder: An EEG Study

* 03-N-0120:
Spinal Substrates of Training-Dependent Improvements in Locomotor Function

* 03-N-0119:
The Effects of an NMDA-Receptor Antagonist in Idiopathic Voice Disorders

* 03-N-0116:
Transcranial Electrical Polarization for the Treatment of Bradykinesia and Rigidity in Patients with Parkinson's Disease.

* 03-N-0112:
Role Of Multimodal Areas For Sensory-To-Motor Processing

* 03-N-0106:
Registry of Fabry Disease: A Multicenter, Longitudinal Observational Study

* 03-N-0089:
Survey of Sensory and Motor Tricks in Focal Dystonia

* 03-N-0081:
Role of the Prefrontal Cortex in Successful Memory Encoding

* 03-N-0075:
Effects of Dopaminergic Agonist Treatment on Spinal Cord Excitability in Restless Legs Syndrome

* 03-N-0074:
Encoding a Motor Memory by Action Observation

* 03-N-0072:
The Physiology of Paroxysmal Hyperkinetic Movement Disorders: A SPECT Study

* 03-N-0057:
Safety, Tolerability, and Efficacy of Rituximab in Patients with Anti-Glycoconjugate Antibody-Mediated Demyelinating Neuropathy: A Double-Blind Placebo-Controlled Randomized Trial

* 03-N-0049:
Repetitive Transcranial Magnetic Stimulation in Chronic Stroke Patients. Dose Effect on Motor Cortex Excitability, Motor Performance, and Safety Using Different Stimulation Parameters.

* 03-N-0048:
The Effect of Peripheral Heterotopic Stimulation on Cortical Excitability in Dystonia

* 03-N-0024:
Drug-Refractory Neocortical Epilepsy: rTMS Treatment

* 03-N-0017:
A Phase I Trial of Focal DC Brain Polarization

* 03-N-0007:
Characterization and Identification of Paroxysmal Hypertensive/Hypercatcholamine Syndromes Among Patients with Pseudopheochromocytoma

* 03-N-0006:
SPECT Evaluation of Nicotinic Cholinergic Receptors in Parkinson's Disease

* 03-N-0004:
Clinical Laboratory Evaluation of Primary Chronic Autonomic Failure

* 03-M-0297:
Cerebral Structure and Function Before and After Pharmacological and Psychological Treatment for PTSD

* 03-M-0296:
Propranolol For the Treatment of Acute Stress Disorder

* 03-M-0292:
Psychobiological Mechanisms of Resilience to Trauma

* 03-M-0211:
Family Study of Affective and Anxiety Spectrum Disorders

* 03-M-0186:
The Psychobiology of Temperament: An fMRI Study

* 03-M-0185:
Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Social Emotional Information and Instrumental Learning

* 03-M-0175:
The Effects of Acute Withdrawal of Estradiol on Mood Symptoms in Women with Perimenopausal Depression

* 03-M-0161:
The Efficacy of 17Beta-Estradiol in Postpartum-Related Depressive Illness

* 03-M-0159:
Kinetic Studies in Whole Body and Brain of [11C]DASB PET Imaging of Serotonin Transporters

* 03-M-0149:
Functional MRI Study of Brain Mechanism Mediating Anhedonia in Major Depression

* 03-M-0143:
Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Modafinil on Cognitive Function in Patients With Schizophrenia and Normal Controls Based on COMT Genotype

* 03-M-0138:
A Screening Protocol to Evaluate Women with Postpartum-Related Mood and Behavioral Disorders

* 03-M-0108:
Cholinergic Modulation of Cognition and Emotion in Mood Disorders: Functional Neuroimaging Studies

* 03-M-0104:
PET Imaging of Dopamine D2 Receptors and Extracellular Dopamine with (18F)Fallypride, D-amphetamine, and Alpha-Methyl-Para-Tyrosine in Healthy Subjects

* 03-M-0102:
Effects of Hydrocortisone Infusion on Processing of Facially Expressed Emotion During Functional Magnetic Resonance Imaging

* 03-M-0093:
Predictability and Aversive Expectancies in Anxiety Disorders

* 03-M-0092:
An Investigation of the Antidepressant Efficacy of an Antiglutamatergic Agent in Bipolar Depression

* 03-M-0035:
Screening and Follow-Up for Childhood Onset Psychotic Disorders

* 03-M-0014:
Neural Circuitry and Risk for Depression in Adolescents: A Study Using Functional Magnetic Resonance Imaging

* 03-M-0001:
Muscarinic Cholinergic Receptor Imaging in Depression

* 03-I-0310:
Immune Response to Influenza Vaccination in HIV-Infected Individuals

* 03-I-0285:
Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases

* 03-I-0263:
Apheresis Procedures to Obtain Plasma or Peripheral Blood Mononuclear Cells for Research Studies

* 03-I-0248:
Pilot (Phase I-II) Study of Pyrimethamine (Daraprim) for the Treatment of the Autoimmune Lymphoproliferative Syndrome (ALPS)

* 03-I-0240:
An Investigation of the Inflammatory Response in Severe Acute Respiratory Syndrome (SARS)

* 03-I-0151:
Evaluation and Treatment of Persons with Serious Complications Associated with Vaccinia Vaccination

* 03-I-0117:
A Single Arm Study of Extracorporeal Photoimmune Therapy With Uvadex For Corticosteroid Sparing in Patients With Corticosteroid-Dependent Crohn's Disease Who May Also Be Refractory or Intolerant to Immunosuppressants and/or Anti-Tumor Necrosis Factor Age

* 03-I-0079:
Screening HIV-Infected Subjects for Vaccine Research Studies

* 03-I-0041:
Determining the Pathogenesis of Systemic Pediatric-Onset Mastocytosis

* 03-I-0025:
Treatment of Chronic Graft Versus Host Disease with Extracorporeal Photopheresis

* 03-I-0021:
Phase I/II Randomized, Double Blind, Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Subcutaneous Bay 50-4798 Admn in Pts with HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to Pts on HAART Alon

* 03-I-0019:
An Open-Label, Pilot Study of Type I Interferon Treatment of Ulcerative Colitis

* 03-HG-0313:
Genetic Analysis of Gray Platelet Syndrome

* 03-HG-0264:
Clinical Investigations into Autosomal Recessive Polycystic Kidney Disease and Congenital Hepatic Fibrosis

* 03-H-0312:
Dietary Nitrate/Nitrite as Sources of Bioactive Nitric Oxide in Patients with Coronary Artery Disease

* 03-H-0282:
Characterization of Cardiac Function in Patients with Hereditary Hemochromatosis Who Are New York Heart Association Functional Class I

* 03-H-0250:
Technical Development of Interventional Cardiovascular Magnetic Resonance Imaging

* 03-H-0249:
A Randomized Trial of Rabbit ATG/CsA vs Campath-1H in Aplastic Anemia Patients with Refractory Pancytopenia or Suboptimal Hematologic Response After h-ATG/CsA Treatment

* 03-H-0217:
Attenuating Insulin Resistance as a Therapeutic Target in the Management of Heart Failure

* 03-H-0209:
Pilot Study of T-Cell-Depleted Peripheral Blood Stem Cell Transplantation from Partially Matched Related Donors for Patients with High-Risk Leukemia

* 03-H-0193:
A Randomized Trial of a Novel Immunosuppressive Combination of ATG, CsA, and Sirolimus (Rapamune® (Registered Trademark)) vs a Slow Taper Cyclosporine Regimen in Subjects with Severe Aplastic Anemia

* 03-H-0105:
The Determination Of Genetic Basis Of Immunodeficiency

* 03-H-0086:
Stem Cell Mobilization For Improvement in Vascular Function and Myocardial Perfusion in Patients Undergoing Cardiac Rehabilitation

* 03-H-0051:
Collection of Blood, Stool, Bone Marrow and/or Tissue Samples from Subjects with Hepatitis-Associated Aplastic Anemia

* 03-EI-0294:
Optical Coherence Tomography Comparative Study

* 03-EI-0275:
Pilot Study on the Use of the NASA-NEI Dynamic Light Scattering (DLS) Device in Detecting lens Changes in the other Eye of Patients with Pre-Senile Cataracts

* 03-EI-0255:
Pilot Study on the Effect of Vitamin A Supplementation on Cone Function in Retinitis Pigmentosa

* 03-EI-0234:
A Phase I Study of NT-501-10 and NT-501-6A.02, Implants of Encapsulated Human NTC-210 Cells Releasing Ciliary Neurotrophic Factor (CNTF), in Patients with Retinitis Pigmentosa

* 03-EI-0179:
Investigation of the Effect of Dietary Docosahexaenoic Acid (DHA) Supplementation on Macular Function in Subjects with Autosomal Dominant Stargardt-Like and Autosomal Recessive Stargardt Macular Dystrophy

* 03-EI-0156:
Measurement of Macular Pigment with Resonant Raman Backscattering Spectroscopy

* 03-EI-0155:
Evaluation of Single Nucleotide Polymorphism (SNP) in Patients with and Subjects without Age-Related Macular Degeneration (AMD)

* 03-EI-0123:
Clinical and Molecular Studies in Families with Congenital or Hereditary Cataracts

* 03-EI-0068:
Identification of Biological Markers in Retinal Vasculitis

* 03-EI-0065:
Preliminary Multi-center Assessment of Laser and Medical Treatment of Diabetic Macular Edema

* 03-EI-0033:
X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies

* 03-EI-0012:
A Pilot Study Using the Dynamic Light Scattering Device (DLS) Combined with Keratoscopy on the Cornea in Vivo

* 03-E-0099:
Pathogenic Studies In Families With Twins Or Siblings Discordant For Systemic Rheumatic Disorders

* 03-DK-0257:
Effect of Leptin Therapy in the Treatment of Severe Insulin Resistance

* 03-DK-0256:
Inhibition of Intestinal Glucose Absorption by the Bioflavonoid Quercetin in the Obese and in Obese Type 2 Diabetes

* 03-DK-0245:
Effect of AC2993 (Synthetic Exendin-4) - Administered Alone or in Combination with Rapamycin and FK506 - On Islet Function in Patients with Type I Diabetes

* 03-DK-0233:
Treatment of Nonalcoholic Steatohepatitis with Metformin

* 03-DK-0226:
Pulse Dexamethasone Over 48 Weeks for Podocyte Disease

* 03-DK-0212:
Long-Term Treatment of Nonalcoholic Steatohepatitis With Pioglitazone

* 03-DK-0204:
Induction of Donor Specific Immunologic Hyporesponsiveness with Thymoglobulin, Sirolimus and Donor Bone Marrow Infusion

* 03-DK-0170:
Nonmyeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation For Severe Congenital Anemias Including Sickle Cell Anemia, Thalassemia, and Diamond Blackfan Anemia

* 03-DK-0168:
Peripheral Blood Granulocyte Mobilization and Gene Expression Profiling in Adult Individuals of African Descent, With and Without Benign Ethnic Neutropenia

* 03-DK-0136:
Low Dose Peginterferon and Ribavirin Therapy for Patients with Chronic Hepatitis C Infected with Genotype 2 or 3

* 03-DK-0132:
The Expression of Connective Tissue Growth Factor and Other Mediators in the Pathogenesis of Chronic Allograft Nephropathy

* 03-DK-0098:
Study of Thyrotropin Releasing Hormone in Normal Volunteers and in Patients with Thyroid or Pituitary Abnormalities

* 03-DK-0071:
Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy

* 03-D-0254:
Studies in Phosphorus Metabolism

* 03-D-0115:
Molecular, Genetic, and Biochemical Effects Of Novel Therapies In Buccal Mucosal Cells

* 03-CH-0225:
Investigation of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome

* 03-CH-0069:
Categorical Representation in Infants' Control of Action

* 03-CC-0306:
A Phase I/II Randomized, Placebo-Controlled Trial to Assess the Safety and Efficacy of Intravenous Immunoglobulin G (Omr-IgG-am) Containing High Anti-West Nile Virus Antibody Titers in Patients with, or at High Risk for Progression to West Nile Virus (WN

* 03-CC-0305:
Investigation of the Natural History of West Nile Infection in Patients with, or at Risk for Progression to West Nile Virus Encephalitis and/or Myelitis

* 03-CC-0301:
Health Beliefs and Health Behavior Practices among Minorities with Rheumatic Diseases

* 03-CC-0258:
Classification of Fetal Breathing Patterns in the Maturing Upper Airway: Spectral Waveform Analysis of Amniotic Fluid Flow Dynamics in Normal Development, Polyhydramnios, and Oligohydramnios

* 03-CC-0247:
Using MR Perfusion Imaging and Hypercapnia to Study Angiogenesis in Multiple Sclerosis Patients

* 03-CC-0166:
Respiratory Cycle Biofeedback During CT Guided Procedures

* 03-CC-0127:
Evaluation of Potential Synergy of Combining Hydroxyurea with Nitric Oxide Donors on Fetal Hemoglobin Synthesis in Patients with Sickle Cell Anemia

* 03-CC-0113:
Treatment of Jugular, Subclavian, and/or Innominate Vein Thrombosis with Low Dose Recombinant Tissue Plasminogen Activator plus Anticoagulation

* 03-CC-0091:
Global Initiative to Characterize Differences in Antiretroviral Pharmacokinetics in HIV-Infected Populations

* 03-CC-0060:
Virtual Functional Anatomy (VFA)

* 03-CC-0052:
Influence of MDR1 Genotype on Indinavir and Saquinavir Pharmacokinetics in Healthy Volunteers

* 03-CC-0028:
Exploring the Relationship Between Personality and Coping Styles in Bone Marrow Transplant Candidates

* 03-C-0311:
Phase II Trial of STI571 (NSC716051) in Patients with Recurrent Meningiomas

* 03-C-0307:
Phase I Study of Depsipeptide in Pediatric Patients with Refractory Solid Tumors

* 03-C-0304:
Pilot Trial of Alemtuzumab and Dose-Adjusted Epoch in Chemotherapy Naive Aggressive T and NK-Cell Lymphomas

* 03-C-0300:
A Phase II Randomized Trial Comparing TNFerade Biologic with Capecitabine and Radiation Therapy Followed by Surgical Resection Versus Capecitabine and Radiation Therapy Followed by Surgical Resection for the Treatment of Rectal Cancer

* 03-C-0299:
Immunization of Patients with Metastatic Melanoma Using a Recombinant GP100 Protein (184V) and a Class I Restricted Peptide from the GP100 Antigen

* 03-C-0284:
A Clinical Trial of the P-Glycoprotein Antagonist, Tariquidar (XR9576), in Combination With Docetaxel in Patients With Lung, Ovarian, and Cervical Cancer: Analysis of the Interaction Between Tariquidar and Docetaxel

* 03-C-0281:
Phase I Study of Anakinra Mediated Tumor Regression and Angiogenesis Inhibition in Patients with Cancers Producing Interleukin-1

* 03-C-0279:
A Prospective Random Assignment Trial Comparing Complete Metastasectomy to Chemotherapy for Selected Patients with Stage IV Melanoma

* 03-C-0278:
A Comparative Study of Pediatric CNS Tumor Activity as Assessed by [18F-] FDG PET Imaging and Proton Magnetic Resonance Spectroscopic Imaging (1H-MRSI)

* 03-C-0277:
Cell Harvest and Preparation for Surgery Branch Adoptive Cell Therapy Protocols

* 03-C-0252:
A Phase I Investigation of IL-12 (NSC 672423)/Pulse IL-2 (Aldesleukin) in Children with Persistent and/or Refractory Neuroblastoma

* 03-C-0243:
Phase I Study of SS1 (dsFv)-PE38 Anti-Mesothelin Immunotoxin in Advanced Malignancies: I.V. Infusion QOD Dosing

* 03-C-0241:
Radiation Therapy and the Natural History of Childhood Malignancies

* 03-C-0228:
Characterization of Serum Proteomic Patterns in Neoplastic and Inflammatory Skin Disease

* 03-C-0221:
A Phase II Study of Isolated Hepatic Perfusion (IHP) with Melphalan Followed by Temozolomide for Patients with Unresectable Hepatic Metastases from Ocular Melanoma

* 03-C-0218:
Open-Label, Intravenous to Oral Switch, Multi Dose, Multi-Center Study to Investigate the Pharmacokinetics, Safety & Tolerability of Voriconazole in Hospitalized Children Aged 2 to Less Than 12 Yrs who Req Tx for the Prev of Systemic Fungal Infection

* 03-C-0216:
A Groupwide Biology and Banking Study for Ewing Sarcoma: Children's Oncology Group

* 03-C-0207:
A Phase II Trial of Talampanel in Patients with Recurrent High-Grade Gliomas

* 03-C-0202:
A Phase I Trial of G3139 (Bcl-2 Antisense) Combined with Cytotoxic Chemotherapy in Relapsed Childhood Solid Tumors

* 03-C-0194:
Phase II Study of the Efficacy and Toxicity of Campath-1H in the Therapy of Adult T-Cell Leukemia

* 03-C-0190:
Trans-Rectal Placement of Prostatic Fiducial Markers Under MR-Guidance in Patients Receiving External Beam Radiotherapy for Prostate Cancer: A Pilot Study

* 03-C-0189:
Phase I Trial of R115777 with Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme

* 03-C-0176:
A Phase I/II Pilot Study of Sequential Vaccinations with rFowlpox-PSA (L155)-TRICOM (PROSTVAC-F/TRICOM) Alone, or in Combination with rVaccinia-PSA (L155)-TRICOM (PROSTVAC-V/TRICOM), and the Role of GM-CSF, in Patients with Prostate Cancer

* 03-C-0172:
Randomized Comparison of Peptide Immunization in Patients at High Risk for Recurrence of Melanoma

* 03-C-0162:
Treatment of Patients with Metastatic Melanoma Using Tumor Infiltrating Lymphocytes (TIL Cells) Transduced with an Interleukin-2 (SBIL-2) Gene following the Administration of a Nonmyeloablative But Lymphocyte Depleting Regimen

* 03-C-0152:
A Phase I Study of Subcutaneous "CYT 99 007" (Interleukin-7) in Patients with Refractory Non Hematologic Malignancy

* 03-C-0150:
A Phase III, Double Blind, Randomized, Multi-Center Study of the Safety and Efficacy of Anidulafungin VS. Fluconazole in the Treatment of Patients with Candidemia and other Forms of Invasive Candidiasis and Prevention of Complications

* 03-C-0114:
A Phase I/II Trial of OSI-774 in Patients With Recurrent Malignant Gliomas and Malignant Gliomas Post Radiation Therapy

* 03-C-0110:
Phase II Study of Intravenous Recombinant Humanized Anti-Vascular Endothelial Cell Growth Factor Antibody (Bevacizumab) in Classical (HIV-Negative) and in AIDS-Associated Kaposi's Sarcoma

* 03-C-0109:
An Open-Label Study of MDX-010 Combined With Interleukin-2 for the Treatment of Patients With Metastatic Melanoma

* 03-C-0096:
PS-341 and PS-341 + Epoch Chemotherapy and Molecular Profiling in Relapsed or Refractory Diffuse Large B-Cell Lymphomas

* 03-C-0094:
A Phase II Open Label Study Of Single Agent MDX-010 For The Treatment of IL-2 Refractory or IL-2 Ineligible Patients With Stage IV Renal Cancer

* 03-C-0085:
A Prospective Random Assignment Trial for Pts With Peritoneal Carcinomatosis From Low Grade Gastrointestinal Adenocarcinoma To Treatment With Operative Debulking and Systemic Chemotherapy With or Without Intra- and Peri-Operative Intraperitoneal Chemothe

* 03-C-0077:
A Pilot Study of EPOCH-F/R Induction Chemotherapy and Reduced-Intensity, HLA-Matched, Related Allogeneic Hematopoietic Stem Cell Transplantation, with Cyclosporine & Methotrexate GVHD Prophylaxis for Refractory or Relapsed Hematologic Malignancies

* 03-C-0066:
Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification of the Disease Gene and Characterization of the Predisposition to Renal Cancer

* 03-C-0062:
A Phase I Study of ZD1839 (Iressa™ (Trademark)), An Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Children with Refractory Solid Tumors

* 03-C-0058:
Phase I Trial of Pirfenidone in Children With Neurofibromatosis Type 1 and Plexiform Neurofibromas

* 03-C-0040:
A Phase I-II Study Of Tumor Vaccine Following Chemotherapy In Patients With Previously Untreated Metastatic Breast Cancer: Vaccine-Induced Bias Of T-Cell Repertoire Reconstitution After T-cell Re-Infusion

* 03-C-0038:
Phase I Study of HeFi-1 in Refractory CD30-Positive Malignancy

* 03-C-0037:
A Phase I/II Trial of Tipifarnib (R115777, ZARNESTRA) in Combination with Tamoxifen in Subjects with Metastatic Breast Cancer

* 03-C-0032:
Intrathecal Gemcitabine Therapy for Neoplastic Meningitis: A Phase I and Pharmacokinetic Study

* 03-C-0030:
Phase I Trial of Depsipeptide Given on Days 1, 3, & 5 in Patients with Thyroid and Other Advanced Cancers

* 03-C-0018:
A Phase II Trial of LY317615 In Patients with Recurrent High-Grade Gliomas

* 03-C-0002:
A Randomized Phase II Study of Peginterferon Alpha-2B (Peg-Intron(TM)) And Thalidomide in Adults with Recurrent High Grade Gliomas

* 03-AT-0251:
An Exploratory Study of the Effects of Oral Glucosamine Administration on Insulin Sensitivity and Capillary Recruitment in Normal and Obese Subjects

* 03-AR-0298:
A Pilot Study with the IL-1 Receptor Antagonist Anakinra/Kineret in Patients with Neonatal Onset Multisystem Inflammatory Disease (NOMID/CINCA Syndrome)

* 03-AR-0208:
A 24-week, Double Blind, Randomized Study to Determine the Effects of 24 Weeks of Dosing with Tripterygium Wilfordii Hook F (TwHF) or Sulfasalazine, in Subjects with Active Rheumatoid Arthritis

* 03-AR-0173:
Studies of the Pathogenesis and Natural History of Neonatal Onset Multisystem Inflammatory Disease (NOMID)

* 03-AR-0133:
Clinically Important Changes in Rheumatoid Arthritis

* 03-AR-0131:
Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study

* 03-AR-0130:
Genetic Determinants of Ankylosing Spondylitis Severity - Cross Sectional Study

* 03-AA-0283:
Influence of Age and Gender on Alcohol Metabolism and Acute Responses

* 03-AA-0013:
Brain Activation in Response to Motivational and Affective Stimuli: Pharmacological Manipulations

* 02-NR-0133:
Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury

* 02-N-0314:
Assessing the Risk of New Ischemic Brain Lesions With On- versus Off-Pump Coronary Artery Bypass Grafting

* 02-N-0301:
ReoPro Retavase Reperfusion of Stroke Safety Study-Imaging Evaluation with Computed Tomography (ROSIE-CT)

* 02-N-0256:
Role of Serum Gonadal and Neuroactive Steroids in the Seizure Susceptibility of Women with Catamenial Epilepsy

* 02-N-0243:
A Phase I/II Randomized, Controlled Study of OGT 918 in Patients with Neuronopathic Gaucher Disease

* 02-N-0236:
Alpha-2 Adrenergic Antagonist Treatment of Parkinson's Disease

* 02-N-0223:
fMRI Languages Studies In Young Children

* 02-N-0216:
Dopaminergic Modulation of Cerebral Connectivity During Sequential Finger Movements: A Combined fMRI-PET Study

* 02-N-0199:
Functional Coupling Of Cortico-Cortical and Cortico-Muscular Connections during Motor Movements: An Electrocorticographic Study of Ipsilateral Motor Control

* 02-N-0182:
Quantitative fMRI in Children and Adults Using Arterial Spin Tagging Techniques

* 02-N-0181:
Evaluation of Density and Pattern of Distribution of GABA A Receptors in Brain of Patients with Tourette's Syndrome Studied with PET using [11C] Flumazenil

* 02-N-0175:
Study of Tics in Patients with Tourette's Syndrome and Chronic Motor Tic Disorder with [15O]H2O PET in Awake and in Sleep States

* 02-N-0154:
ReoPro Retavase Reperfusion of Stroke Safety Study -- Imaging Evaluation

* 02-N-0135:
A Neuroimaging Study of Automatic Movements

* 02-N-0132:
In Vivo Mapping Of Structural Brain Abnormalities with Voxel-Based Morphometry In Patients With Primary Focal Dystonia

* 02-N-0128:
Evaluation of Tourette's Syndrome with Multimetabolite H-Magnetic Resonance Spectroscopy at 1.5 and 3T

* 02-N-0122:
Natural History and Immunopathogenesis of Stiff Person Syndrome (SPS)

* 02-N-0121:
Study of Immune Dysregulation in Patients with Sporadic Inclusion Body Myositis (s-IBM)

* 02-N-0109:
Real-time Analysis of Scalp Electroencephalography During Production of Human Voluntary Movement

* 02-N-0105:
Placebo Controlled Study of Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Parkinson's Disease

* 02-N-0082:
Enhancement of Use-Dependent Plasticity by Somatosensory Stimulation in Chronic Stroke

* 02-N-0078:
Role of the Intact Hemisphere in Recovery of Motor Function after Stroke

* 02-N-0069:
Brain Areas Involved in Temporal Linkage of Bilateral Movements

* 02-N-0068:
Comparison of Externally and Self-Initiated Movements

* 02-N-0027:
Brain Activation in Motor and Vocal Tics in Patients with Tourette's Syndrome or Chronic Motor or Vocal Tic Disorder Using Blood Oxygenation Level Dependent Functional MRI

* 02-N-0014:
Research Study of Specimens Obtained During Epilepsy Surgery

* 02-N-0011:
EEG Analysis of Ideomotor Apraxia

* 02-N-0001:
Testing A Model of the Representational Knowledge Stored in the Human Prefrontal Cortex

* 02-M-0321:
fMRI Investigation of Explicit Cue and Contextual Fear

* 02-M-0317:
Glucocorticoid and Mineralocorticoid Receptor Function in Post Traumatic Stress Disorder

* 02-M-0305:
The Effect of Short-Term Statin and NSAID Treatment on CSF Beta-amyloid

* 02-M-0281:
The Characterization of Childhood Onset Obsessive Compulsive Disorder and the PANDAS Subgroup

* 02-M-0263:
Effect of Alprazolam on Fear-Potentiated Startle in Humans

* 02-M-0251:
Antiglucocorticoid Therapy in Bipolar Depression with Mifepristone (RU486)

* 02-M-0239:
Randomized, Double-Blinded, Placebo Controlled Study Of The Effects Of Tolcapone On Cognitive Function In Patients With Schizophrenia And Normal Controls Based On COMT Genotype

* 02-M-0231:
An Investigation of the Antidepressant Efficacy of Memantine, an NMDA Antagonist with Neurotrophic Properties in Major Depression

* 02-M-0176:
A Double-Blind Randomized Placebo-Controlled Trial of Felbamate in Treatment Resistant Bipolar Depression

* 02-M-0162:
Tryptophan Depletion and PET Scanning in Remitted Depressed Patients Off Treatment and Healthy Controls

* 02-M-0155:
The Effects of Cortisol and Norepinephrine Modulation on Emotional and Nonemotional Processing

* 02-M-0136:
Combined Treatment With A Benzodiazepine (Clonazepam) And A Selective Serotonin Reuptake Inhibitor (Paroxetine) For Rapid Treatment Of Panic Disorder With Depression

* 02-M-0120:
The Efficacy of Phytoestrogens and Selective Estrogen Receptor Modulators in Perimenopause-Related Depression

* 02-M-0095:
MRI Contrast Imaging in the Evaluation and Follow-up of Patients with Memory Disorder and Healthy Controls

* 02-M-0092:
Reward-Related Processes and Brain Function

* 02-M-0089:
Alpha(2)-Adrenoreceptor (AR) Subtype Polymorphisms and Physiological Responses to Alpha(2)-AR Agonist and Antagonist Drugs

* 02-M-0085:
A Double Blind Study Examining the Efficacy of Clozapine and a Study of the Pathophysiology in Treatment Resistant Mania

* 02-M-0047:
Serotonin1A Receptor and Serotonin Transporter Imaging In Mood Disorders

* 02-M-0037:
A Double-Blind Study Examining the Efficacy of the Protein Kinase C Inhibitor Tamoxifen in the Treatment of Acute Mania

* 02-M-0036:
A Behavioral and Functional Neuroimaging Study of Inhibitory Motor Control

* 02-M-0021:
Severe Mood and Behavioral Dysregulation in Children: Pathophysiology and Treatment with Lithium

* 02-M-0018:
An Investigation of the Antidepressant Efficacy of a Dopamine Agonist with Neurotrophic Properties in Bipolar Disorder

* 02-M-0007:
Adolescent Medial Temporal Lobe Function in Health and Illness

* 02-M-0003:
Fear Conditioning Using Computer-Generated Virtual Reality

* 02-M-0002:
Serotonin 1A Receptor Imaging and Benzodiazepine Receptor Imaging in Panic Disorder and Posttraumatic Stress Disorder

* 02-I-0308:
A Pilot Study of Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) for the Evaluation of the Autoimmune Lymphoproliferative Syndrome and ALPS-Associated Lymphoma

* 02-I-0286:
A Pilot Study of the Safety and Efficacy of Imatinib Mesylate in Reducing Eosinophilia in Patients with the Myeloproliferative Form of Hypereosinophilic Syndrome (HES) or Non-Myeloproliferative HES Refractory to Standard Therapy

* 02-I-0277:
Regulation of the Proliferation and Survival of Normal and Neoplastic Human Mast Cells

* 02-I-0232:
HIV Expression in Patients with Viral Loads Suppressed on HAART

* 02-I-0202:
Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-Infected Patients

* 02-I-0171:
Open Label Limited Access Protocol of Posaconazole in Invasive Fungal Infections

* 02-I-0147:
Genetic Studies of Chronic Active Epstein-Barr Virus Infection

* 02-I-0127:
Screening Subjects for HIV Vaccine Research Studies

* 02-I-0110:
Natural History of Anthrax: A Study of Primary Infected, Recovered, and Exposed (SPoRE) Individuals and Evaluation of AVA Vaccinated Recipients

* 02-I-0096:
Rituximab (Anti-CD20) for the Treatment of Hepatitis C Associated Cryoglobulinemic Vasculitis

* 02-I-0086:
Leukapheresis Procedures to Study HIV-Specific Immunity

* 02-I-0066:
Studies of Specific Immune Responses in Human Peripheral Blood Cells in HIV-Infected and HIV-Uninfected Volunteers

* 02-I-0057:
Ex Vivo Retroviral Gene Transfer For Treatment of X-Linked Severe Combined Immunodeficiency (XSCID)

* 02-I-0055:
Evaluation, Treatment and Follow up of Patients with Lyme Disease

* 02-I-0019:
Granulocyte-Colony Stimulating Factor Treatment for Crohn's Disease

* 02-I-0013:
A Randomized, Controlled Trial of Short Cycle Intermittent Versus Continuous HAART for the Treatment of Chronic HIV Infection

* 02-H-0250:
A Phase I/II Study of HLA-matched Mobilized Peripheral Blood Hematopoietic Stem Cell Transplantation for Advanced Mycosis Fungoides/Sezary Syndrome Using Nonmyeloablative Conditioning with Campath-1H

* 02-H-0227:
A Pilot Study to Determine if Transfer of Gpi-Linked Proteins Occurs Following Transfusion of Red Cells to Patients with Paroxysmal Nocturnal Hemoglobinuria

* 02-H-0059:
Evidence of Procedural Embolism Complicating Renal Artery Stenting

* 02-H-0050:
Technical Development of Cardiovascular MRI in Patients

* 02-EI-0255:
Prevalence and Risks for Posterior Subcapsular Cataracts in Volunteer Granulocytapheresis Donors

* 02-DK-0160:
Peripheral Blood Stem Cell Collection from Adult Volunteers

* 02-DK-0107:
Investigation of Neurodegeneration in Glycosphingolipid Storage Disorders

* 02-DK-0065:
Combination of Pegylated Interferon and Ribavirin as Therapy for Patients with Chronic Hepatitis C with and without Renal Disease

* 02-DK-0022:
Long-Term Efficacy of Leptin Replacement in Treatment of Lipodystrophy

* 02-DC-0008:
Assessment of Pre- and Post-Synaptic Dopamine Function in Developmental Stuttering Using 11C-Raclopride and Positron Emission Tomography

* 02-D-0169:
Complex Regional Pain Syndrome Proteomics Study

* 02-CH-0311:
Investigations into Inborn Errors of Cholesterol Synthesis and Related Disorders

* 02-CH-0287:
Treatment of Leiomyomata with the Selective Progesterone Receptor Modulator CDB-2914

* 02-CH-0278:
Dyadic Interactions in Depressed and Non-Depressed Mothers with Their Infants

* 02-CH-0219:
Pharmacokinetic Comparison of Two Preparations of the Selective Progesterone Receptor Modular CDB2914

* 02-CH-0032:
(131)I-Metaiodobenzylguanidine Treatment of Malignant Pheochromocytoma

* 02-CH-0023:
Studies of Pediatric Patients with Metabolic or Other Genetic Disorders

* 02-CC-0289:
Double-Blind, Vehicle-Controlled Study to Evaluate Apoptosis in Basal Cell Carcinoma Treated with Aldara™ (Trademark) (Imiquimod) Cream, 5% Applied Once or Twice a Day

* 02-CC-0266:
Acute Cardiac Allograft Cellular Rejection and Cardiac Allograft Vasculopathy: Identification of Diagnostic Biomarkers and Target Pathways for Preventive Therapy

* 02-CC-0245:
The Use of Microdialysis/Acupuncture Needle to Assess the Local Tissue Milieu in Active and Latent Myofascial Trigger Points in the Upper Trapezius Muscle in Individuals With and Without Neck Pain

* 02-CC-0244:
Radiofrequency Ablation of Painful Soft Tissue Neoplasms

* 02-CC-0208:
Endothelial Dysfunction as a Risk Factor in HIV Study

* 02-CC-0203:
Heparin vs. Lepirudin Flushes in Preventing Withdrawal Occlusion of Tunneled, Open-ended Venous Access Devices: A Blinded, Randomized, Clinical Trial

* 02-CC-0168:
Pharmacokinetics of Valganciclovir in Kidney and Kidney/Pancreas Transplant Recipients

* 02-CC-0146:
A Pilot Study Evaluating the Assessment Process for Constipation in Pediatric Oncology Patients who are Receiving Vinca Alkaloids and/or Narcotics

* 02-CC-0053:
A Randomized Study Evaluating the Process and Outcomes of the Pain and Palliative Care Team Intervention

* 02-CC-0045:
A Prospective (Cohort) Study to Identify Factors Affecting Morbidity Following the Diagnosis and Treatment of Patients with Breast Cancer: A Multi-Institutional Study Between NIH/RMD and NNMC/BCC

* 02-CC-0044:
Morbidity Following the Diagnosis and Treatment of Patients with Breast Cancer: A Multi-Institutional Study Between the National Institutes of Health (NIH) Rehabilitation Medicine Department (RMD) and the National Naval Medical Center (NNMC) Breast Care

* 02-C-0313:
Cancer Risk in Xeroderma Pigmentosum Heterozygotes

* 02-C-0303:
Phase II Pilot Study of Clinical Activity and Proteomic Pathway Profiling of the EGFR Inhibitor, ZD1839 (Iressa; Gefitinib), In Patients With Epithelial Ovarian Cancer Or Cervical Cancer

* 02-C-0268:
Prospective Study of Risk-Reducing Salpingo-Oophorectomy and Longitudinal CA-125 Screening Among Women at Increased Genetic Risk of Ovarian Cancer

* 02-C-0259:
Pilot Study of Allogeneic/Syngeneic Blood Stem Cell Transplantation in Patients with High-Risk and Recurrent Pediatric Sarcomas

* 02-C-0258:
Acquisition of Blood, Bone Marrow, Tumor, or Tissue Samples

* 02-C-0241:
A Phase I Trial of UCN-01 and Prednisone in Patients with Refractory Solid Tumors and Lymphomas

* 02-C-0229:
A Phase II Clinical Trial of Ixabepilone (BMS-247550, NSC 710428), An Epothilone B Analog, in Patients with Breast Carcinoma

* 02-C-0226:
Are the Proteomic Profiles of Serum and Urine Predictive for Clinical Outcome After Definitive Radiotherapy for Localized Prostate Cancer? A Preliminary Cohort Study

* 02-C-0215:
Amifostine as a Rectal Protector During External Beam Radiotherapy for Prostate Cancer: A Phase II Study

* 02-C-0212:
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

* 02-C-0211:
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma

* 02-C-0210:
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Blood and Lymph Node Malignancy

* 02-C-0207:
A Phase II Study of MR-Guided High Dose Rate Brachytherapy Boosts For Prostate Cancer

* 02-C-0205:
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion in Patients with Pulmonary and Pleural Malignancies

* 02-C-0194:
Rectal Aberrant Crypt Foci And Other Intermediate Biomarkers For Sporadic Colorectal Neoplasia: Cross-Sectional Prevalence And Modulation By Celecoxib

* 02-C-0193:
A Phase II Study Of Pegylated Interferon Alfa-2b (Peg-Intron (TM)) In Children With Diffuse Pontine Gliomas

* 02-C-0190:
Phase II Clinical Trial with Proteomic Profiling of Imatinib Mesylate (Gleevec; STI571), a PDGFR and C-Kit Inhibitor, in Patients with Refractory or Relapsed Epithelial Ovarian Cancer, Fallopian Tube and Primary Peritoneal Cancer

* 02-C-0186:
Eligibility Screening of Patients with CNS Tumors for NCI Clinical Research Protocols.

* 02-C-0179:
Collection of Blood from Patients with Cancer

* 02-C-0178:
Multidisciplinary Etiologic Study of Familial Testicular Cancer

* 02-C-0159:
The Birt Hogg-Dube Syndrome: Identification of the Disease Gene and Characterization of the Predisposition of Renal Cancer

* 02-C-0150:
Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children

* 02-C-0149:
A Phase I Trial of High Dose Ketoconazole Plus Weekly Docetaxel in Metastatic Androgen Independent Prostate Cancer

* 02-C-0144:
Establishment of Normal High Risk Breast Epithelial Cell Cultures, and A High Risk Cell Line and Tissue Repository from Breast Tissue from Women at High Risk of Breast Cancer

* 02-C-0141:
Phase I Trial and Pharmacokinetic Study of ABT-751, An Orally Bioavailable Tubulin Binding Agent, on a 7 Day and 21 Day Dosing Schedule in Pediatric Patients With Refractory Solid Tumors

* 02-C-0140:
A Prospective National Study to Molecularly and Genetically Characterize Human Gliomas

* 02-C-0130:
A Phase II Clinical Trial of BMS-247550 (NSC710428), An Epothilone B Analog, In Patients With Renal Cell Carcinoma

* 02-C-0083:
A Multidose Phase I Study of Oral CC5013, a Thalidomide Derivative, in Patients with Refractory Metastatic Cancer

* 02-C-0077:
Characterization of High Risk Breast Duct Epithelium by Cytology, Breast Duct Endoscopy, and cDNA Gene Expression Profile

* 02-C-0052:
Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes

* 02-C-0031:
Phase I Trial and Pharmacokinetic Study of BMS-247550 (NSC 710428), an Epothilone B Analog, in Pediatric Patients with Refractory Solid Tumors

* 02-C-0017:
Biological Specimen Collection for Laboratory Methods Development and for Training Purposes

* 02-AT-0260:
A Phase I Study of the Effect of Mistletoe Extract, a Complementary, Medicine Botanical, on Pharmacokinetics, Pharmacodynamics and Safety of Gemcitabine in Patients with Advanced Solid Tumors

* 02-AT-0172:
A Randomized Study of Electroacupuncture Treatment for Delayed Chemotherapy-Induced Nausea and Vomiting in Patients with Pediatric Sarcomas

* 02-AR-0272:
A Phase I, Open-Labeled, Dose-Ascending Clinical Trial of Immunotherapy of MRA, A Humanized Anti-IL 6 Receptor Monoclonal Antibody, In Patients with Systemic Lupus Erythematosus

* 02-AR-0267:
Role of the Antibody Against NR2 Glutamate Receptor in Cognitive Dysfunction in Patients with Systemic Lupus Erythematosus

* 02-AR-0170:
Suppression of the Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis in Women with Rheumatoid Arthritis

* 02-AR-0156:
A Randomized, Double-Blind, Placebo-Controlled Trial of Infliximab In Patients With Dermatomyositis and Polymyositis

* 02-AR-0131:
Collection Of Blood Components Using Apheresis From Patients With Rheumatic Diseases And Healthy Volunteers

* 02-AR-0081:
A Randomized Double Blind Controlled Intra-Patient Dose Escalation Phase II Trial of Infliximab in Pediatric Patients with Refractory Juvenile Rheumatoid Arthritis

* 01-N-0260:
Neurophysiology of Motor Disorders in Spastic Diplegia

* 01-N-0220:
Motor Learning: Behavioral and Physiologic Studies in Normal Volunteers and Stroke Patients

* 01-N-0206:
Phenotype/Genotype Correlations in Movement Disorders

* 01-N-0188:
Neurophysiological Studies of Focal and Generalized Forms of Dystonia using Transcranial Magnetic Stimulation (TMS)

* 01-N-0187:
Phenotype/Genotype Correlations in Inherited Myopathies

* 01-N-0181:
Language Stimuli Screening in Children

* 01-N-0174:
The Etiology and Pathogenesis of Neurometabolic Disorders

* 01-N-0167:
Phase I Clinical Trial to Establish the Maximum Tolerated Dose of Idebenone in Children, Adolescents, and Adults with Friedreich's Ataxia

* 01-N-0166:
The Natural History and Pathogenesis of Mucolipidosis Type IV

* 01-N-0149:
Diagnostic Evaluation of Patients with Neuromuscular Diseases

* 01-N-0148:
Spasticity: Physiologic Studies

* 01-N-0147:
Trial of Amlodipine Combined with Botulinum Toxin Injections for Focal Dystonia

* 01-N-0145:
Screening: Neurologic Disorders with Muscle Stiffness

* 01-N-0139:
Evaluation and Treatment of Patients with Epilepsy

* 01-N-0085:
Establishing the Pathophysiology of Primary Spinal Syringomyelia

* 01-N-0007:
Evaluation, Pathogenesis, and Treatment of Patients with Cerebrovascular Disease

* 01-N-0002:
Improvements of Hand Function in Chronic Stroke Related to Upper Arm Anesthesia

* 01-M-0192:
Fluoxetine's Effects on Attention and Emotional Memory in Anxious and Depressed Youth

* 01-M-0185:
Effects of Arousal and Stress on Classical Conditioning

* 01-M-0175:
Treatment of Winter Depression with Pharmacological Suppression of Melatonin Secretion

* 01-M-0152:
Adolescence, Puberty, and Emotion Regulation: An fMRI Study

* 01-M-0128:
Pilot Study of Immunomodulatory versus Antiinflammatory Therapy in Alzheimer's Disease

* 01-M-0064:
Anatomic MRI Brain Imaging of White Matter in Children

* 01-I-0202:
Natural History, Genetics, Phenotype and Treatment of Mycobacterial Infections

* 01-I-0194:
A Non-Randomized, Open label, Study to Assess Hepatitis C Viral Kinetics in Predicting the Clinical Response in Patients with Hepatitis C Infection Coinfected with HIV-1 Treated with Peginterferon Alpha-2b and Ribavirin

* 01-I-0171:
Substudies of ESPRIT: ESPRIT Influenza Vaccine Substudy (FLUVAC) and ESPRIT Tetanus-Pneumococcal Vaccine Substudy (TEPVAC)

* 01-I-0153:
The Immune Basis for the Gastrointestinal Complications of Common Variable Immunodeficiency

* 01-I-0013:
HLA-Matched, Peripheral Blood Stem Cell Transplantation Using Low Intensity Conditioning to Treat Patients with Chronic Granulomatous Disease Who Are Actively Infected

* 01-I-0004:
An Assessment of the Relationship Between Antiretroviral Drug Genotype/Phenotype (IC50) and Antiretroviral Activity in HIV-Infected, Drug-Experienced Patients with Suboptimal Suppression of Plasma Viral Load

* 01-HG-0232:
PET Scanning in Parkinson's Disease

* 01-HG-0226:
Evaluation of Immune Responses to Vaccines in Primary Immunodeficiencies

* 01-HG-0189:
Treatment of SCID due to ADA Deficiency with Autologous Cord Blood or Bone Marrow CD34+ Cells Transduced with a Human ADA Gene

* 01-HG-0109:
Natural History Study of the Clinical and Molecular Manifestations of Smith-Magenis Syndrome (SMS)

* 01-HG-0094:
Molecular Analysis of Microphthalmia/Anophthalmia

* 01-H-0223:
Inhaled Nitric Oxide and Transfusion Therapy for Patients with Sickle Cell Anemia and Secondary Pulmonary Hypertension

* 01-H-0163:
Tissue Collection Protocol for Individuals with Cystic Fibrosis

* 01-H-0162:
Ex Vivo Selective Depletion of Alloreactive Donor T-Lymphocytes Utilizing RFT5-SMPT-dgA, a Specific Anti-Interleukin-2 Receptor Immunotoxin: Reducing GVHD Risk Associated with HLA-Matched Nonmyeloablative Peripheral Blood Stem Cell Transplantation

* 01-H-0097:
Investigation of G-CSF-Induced Stem Cell Mobilization Potential in Patients with Diamond-Blackfan Anemia

* 01-H-0083:
A Pilot Study of G-CSF Induced Stem Cell Mobilization Potential in Patients with Relapsed Severe Aplastic Anemia

* 01-H-0010:
Low Intensity Preparative Regimen Followed by HLA-Matched, Mobilized Peripheral Blood Stem Cell Transplantation for Systemic Mastocytosis

* 01-EI-0102:
Evaluation and Treatment Protocol for Potential Research Subjects with Inherited Ophthalmic Diseases

* 01-EI-0046:
Evaluation and Treatment Protocol of Patients with Corneal and External Diseases

* 01-DK-0249:
Ingested Interferon Alpha: Prolongation or Permanence of the "Honeymoon" Phase in Newly Diagnosed Diabetes Mellitus

* 01-DK-0247:
Treatment of Chronic Delta Hepatitis with Pegylated Interferon

* 01-DK-0246:
Combination of Lamivudine and Adefovir Dipivoxil for Treatment of Chronic Hepatitis B

* 01-DK-0122:
Collection and Storage of Umbilical Cord Hematopoietic Stem Cells for Sickle Cell Disease Therapy

* 01-DK-0088:
Determining the Prevalence and Prognosis of Secondary Pulmonary Hypertension in Adult Patients with Sickle Cell Anemia

* 01-DK-0062:
Genetic Analysis of Familial Keloids

* 01-DK-0053:
Permeability Factor in Focal Segmental Glomerulosclerosis

* 01-DC-0230:
Studies of Deficits in the Sense of Taste

* 01-DC-0229:
Genetic Analysis of Hereditary Disorders of Hearing and Balance

* 01-DC-0228:
Clinical and Molecular Analysis of Enlarged Vestibular Aqueducts

* 01-DC-0099:
Evaluation for NIDCD Head & Neck Surgery Branch Clinical Research Protocols

* 01-D-0184:
Evaluation and Treatment of Skeletal Diseases

* 01-D-0076:
Morphine, Nortriptyline and Their Combination in Sciatica Treatment

* 01-CH-0096:
Catecholamine Reserve and Exercise Tolerance in Subjects with Congenital Adrenal Hyperplasia and in Healthy Controls

* 01-CH-0086:
Pilot Study of Cystagon as a Potential Therapy for Infantile Neuronal Ceroid Lipofuscinosis

* 01-CC-0237:
Toward a Theory of Technology Dependency and Health Related Quality of Life (HRQL): A Test of a Model in Patients with an Implantable Cardioverter Defibrillator

* 01-CC-0231:
A Prospective Study of Transfusion-Transmitted Infections

* 01-CC-0135:
Effect of Task on Oral Pressure Dynamics During Swallowing

* 01-CC-0077:
Platelet Dysfunction in Patients Treated with SSRI Versus Non-SSRI Antidepressants

* 01-CC-0045:
Studies of Phlebotomy Therapy in Hereditary Hemochromatosis

* 01-CC-0044:
Task-Induced Physiological and Biomechanical Changes of the In Vivo Human Tongue

* 01-C-0235:
Combination Antibody Therapy with Apolizumab (1D10) and Rituximab (CD20) in Relapsed Lymphoma and CLL

* 01-C-0222:
A Phase II Randomized, Cross-Over, Double-Blinded, Placebo-Controlled Trial of the Farnesyltransferase Inhibitor R115777 in Pediatric Patients with Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

* 01-C-0215:
A Phase I Study of Hepatic Arterial Infusion of Escalating Dose Melphalan with Venous Filtration for Unresectable Cancers of the Liver

* 01-C-0213:
Phase I Study of BL22, a Recombinant Immunotoxin for Chronic Lymphocytic Leukemia and CD22+ Lymphomas

* 01-C-0203:
Long-Term Survival with HIV: A Study of the Psychological and Behavioral Factors Associated with the Transition From Adolescence To Young Adulthood

* 01-C-0196:
A Phase I Trial and Pharmacokinetic Study of R115777 in Pediatric Patients With Refractory Leukemias

* 01-C-0173:
A Pilot Study to Evaluate Angiogenesis after Treatment with Bevacizumab (Anti-VEGF Humanized Monoclonal Antibody) in Previously Untreated Patients with Inflammatory Breast Cancer or Locally Advanced Breast Cancer

* 01-C-0158:
Protocol to Assess Vascularity in Kaposi's Sarcoma Lesions Utilizing Non-Invasive Imaging Techniques

* 01-C-0157:
Eligibility Screening and Tissue Procurement for the National Cancer Institute (NCI), Pediatric Oncology Branch (POB) Clinical Research Protocols

* 01-C-0144:
Surveillance of Invasive Fungal Infections in Bone Marrow/Stem Cell and Solid Organ Transplantation Recipients: A Prospective, Multicenter Study

* 01-C-0129:
Eligibility Screening and Tissue Procurement for the National Cancer Institute (NCI) Center for Cancer Research (CCR) Clinical Protocols

* 01-C-0125:
Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies

* 01-C-0124:
A Phase I Study of an Oral Histone Deacetylase Inhibitor, MS-275, in Refractory Solid Tumors and Lymphomas

* 01-C-0123:
A Phase II Study of Intrathecal Topotecan (NSC #609699) in Patients with Refractory Meningeal Malignancies, A COG Group-Wide Study

* 01-C-0104:
A Phase I Study of Concomitant Therapy with Proteasome Inhibitor PS-341 and Radiation in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

* 01-C-0093:
A Phase III Prospective Random Assignment Trial of Regional and Systemic Chemotherapy with or without Initial Isolated Hepatic Perfusion for Patients with Metastatic Unresectable Colorectal Cancers of the Liver

* 01-C-0091:
Phase I Trial and Pharmacokinetic Study of Tariquidar (XR9576), a P-Glycoprotein Inhibitor, in Combination with Doxorubicin, Vinorelbine or Docetaxel in Pediatric Patients with Refractory Solid Tumors Including Brain Tumors

* 01-C-0070:
Evaluation of the Natural History of Patients with Tumors of the Central Nervous System

* 01-C-0067:
A Phase II Study of Interleukin-12 with either Liposomal Doxorubicin or 96 Hour Continuous Infusion Paclitaxel in AIDS-Associated Kaposi's Sarcoma Followed by Chronic Administration of Interleukin-12

* 01-C-0049:
Phase II Trial of Depsipeptide in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma

* 01-C-0038:
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples from Patients with HIV Infection, KSHV Infection, Viral-related Pre-malignant Lesions, and/or Cancer

* 01-C-0037:
Late Effects of Treatment in Survivors of Pediatric Sarcomas

* 01-C-0032:
Immunization of HLA-A*0201 or HLA-DPB1*04 Patients with Metastatic Cancer Using Epitopes from the ESO-1 Antigen

* 01-C-0030:
Short-Course EPOCH-Rituximab for Untreated CD-20+ HIV-Associated Lymphomas

* 01-C-0011:
Phase I Study of SS1 (dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion For 10 Days

* 01-C-0009:
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-up Study

* 01-C-0008:
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Pilot Study

* 01-AR-0227:
Natural History of Rheumatic Disease in Minority Communities

* 01-AA-0141:
Polyunsaturated Fatty Acids and the Neurochemistry of Cardiovascular and Behavioral Responses in Aggressive Alcoholics

* 01-AA-0098:
The Effect of Fluoxetine on Measures of Domestic Violence

* 01-AA-0090:
Effects of Acute Plasma Tryptophan Depletion on Serotonin Receptor Occupancy and Binding Affinity using PET in Healthy and Alcoholic Human Subjects

* 00-N-0158:
Trial of Intracerebral Infusion in Patients with Medically Intractable Epilepsy

* 00-N-0145:
Dose-Escalation Trial of Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor for the Treatment of PSP

* 00-N-0140:
A Prospective Natural History Study of VHL Patients with CNS Hemangioblastomas

* 00-N-0095:
Brain Activation During Developmental Speech Production and Speech Perception

* 00-N-0089:
Genetic Analysis of the Chiari I Malformation

* 00-N-0082:
Characterization of Brain Activation at 1.5 and 3.0 Tesla Using Perfusion Images and Blood Oxygen Level Dependent Images

* 00-N-0072:
Diagnosis of Neuromuscular Disorders with Specialized Electromyographic Studies

* 00-N-0057:
Positron Emission Tomography Imaging of Activation-Induced Signal Transduction in Human Brain

* 00-N-0043:
Clinical and Molecular Manifestations of Inherited Neurological Disorders

* 00-N-0009:
Detection of Glioblastoma or Anaplastic Astrocytoma Cells in the Circulation During Surgical Resection

* 00-M-0203:
The P.O.W.E.R. STUDY (Premenopause, Osteopenia/Osteoporosis, Women, Alendronate, Depression)

* 00-M-0198:
The Phenomenology and Neurophysiology of Affective Dysregulation in Children and Adolescents with Bipolar Disorder

* 00-M-0177:
Transcranial Magnetic Stimulation Studies of Visual Attention

* 00-M-0103:
The Treatment of Menstrually-Related Mood Disorders with Continuous Gonadal Steroid Replacement

* 00-M-0085:
Structural and Functional Imaging of Neuropsychiatric Patients and Normal Volunteers with 3.0 Tesla MRI and Magnetoencephalography

* 00-M-0067:
The Evaluation and Follow-up of Patients with Obsessive-Compulsive Disorder and OC Spectrum Disorders

* 00-M-0049:
Factors in Susceptibility to Ischemic Heart Disease in Major Depression: Documentation of Insulin Resistance in Patients with Major Depression Utilizing the Hyperinsulinemic Euglycemic Glucose Clamp

* 00-I-0164:
Cognitive Function in Leukocyte Disorders

* 00-I-0159:
Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection (Job) Syndrome

* 00-I-0110:
Analysis of HIV Genetic Variation in Patients Prior to Initiation of Highly Active Antiretroviral Therapy

* 00-I-0099:
Langherhans' Cell Function and Inflammatory Responses in Skin of Normal Volunteers and Patients with Helminth Infections Using the Suction Blister Technique

* 00-HG-0223:
Decisions of Female Adolescents about Carrier Testing in Families with X-Linked Severe Combined Immunodeficiency (XSCID)

* 00-HG-0209:
Molecular and Clinical Studies of Primary Immunodeficiency Diseases

* 00-HG-0191:
Clinical, Molecular and Biochemical Characterization of Familial Encephalopathy with Neuroserpin Inclusion Bodies

* 00-HG-0153:
Investigations into Chediak-Higashi Syndrome and Related Disorders

* 00-HG-0141:
Clinical, Biochemical, and Molecular Investigations into Alkaptonuria

* 00-HG-0058:
Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)

* 00-H-0147:
Treatment with Octreotide in Patients with Lymphangioleiomyomatosis

* 00-H-0051:
Cutaneous Tumorigenesis in Patients with Tuberous Sclerosis

* 00-H-0029:
A Pilot Study of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) in Patients with Moderate Aplastic Anemia, Pure Red Cell Aplasia, Diamond Blackfan Anemia, Relapsed Aplastic Anemia, or Refractory Aplastic Anemia

* 00-EI-0204:
Evaluation and Treatment Protocol for Patients with Intraocular Inflammatory Disease (Uveitis)

* 00-EI-0139:
Evaluation and Treatment Protocol for Patients with Retinal Disease

* 00-EI-0135:
Study of Association of Serum Factors with Diabetic Retinopathy

* 00-DK-0221:
Evaluation of the Immune Response in Humans After Exposure to Hepatitis C Virus

* 00-DK-0152:
Use of Laparoscopy for Localization and Resection of Insulinomas of the Pancreas

* 00-DK-0125:
Immunogenetics of Hepatitis C Virus Infection

* 00-DK-0107:
Search for Novel Methods to Detect Acute Renal Failure

* 00-DK-0042:
Pirfenidone in Focal Segmental Glomerulosclerosis Phase II Study

* 00-DC-0176:
Genetic Studies of Tune Deafness

* 00-DC-0073:
Identification of Hereditary Auditory Temporal Processing Deficits

* 00-D-0200:
Neurotropin for Acute Dental Pain and for Chronic Neuropathic Pain

* 00-D-0190:
Cytokine Responses to Acute Inflammation in the Oral Surgery Model

* 00-D-0183:
Effects of the Aromatase Inhibitor Letrozole on Pubertal Progression and Indices of Bone Turnover in Girls with Precocious Puberty and McCune-Albright Syndrome (MAS)

* 00-D-0055:
Genetics of Pain

* 00-CH-0219:
Turner Syndrome: Genotype and Phenotype

* 00-CH-0189:
FSH-Stimulated Inhibin B as a Marker for Early Ovarian Insufficiency

* 00-CH-0180:
Endocrine Studies in Health and Disease

* 00-CH-0160:
Clinical and Molecular Analysis of ACTH-Independent Steroid Hormone Production in Adrenocortical Tissue

* 00-CH-0136:
A Trial of Pamidronate in Children with Osteogenesis Imperfecta

* 00-CH-0134:
Effects of Metformin on Energy Intake, Energy Expenditure, and Body Weight in Overweight Children with Insulin Resistance

* 00-CH-0127:
Evaluation of Patients with Endocrine-Related Conditions

* 00-CH-0093:
Diagnosis, Pathophysiology, and Molecular Biology of Pheochromocytoma

* 00-CH-0045:
Hormone Replacement in Young Women with Premature Ovarian Failure

* 00-CH-0035:
The Development of Categorization

* 00-CC-0165:
Filgrastim-Mobilized Peripheral Blood Stem Cells for Primary Allogeneic Transplantation Using Unrelated Donors Participating in the National Marrow Donor Program (NMDP)

* 00-CC-0096:
Investigations in Discourse Processes

* 00-C-0201:
Active Immunization of Sibling Stem Cell Transplant Donors Against Purified Myeloma Protein of the Stem Cell Recipient with Multiple Myeloma in the Setting of Non-Myeloablative, HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation

* 00-C-0193:
A Study of the Effects of Potent Anti-HIV Therapy on Parameters Hypothesized to Be Related to the Pathogenesis of Kaposi's Sarcoma (KS) in HIV-Infected Individuals

* 00-C-0181:
Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols

* 00-C-0154:
A Randomized Phase II Study of a PSA-Based Vaccine in Patients with Localized Prostate Cancer Receiving Standard Radiotherapy

* 00-C-0121:
A Phase I Investigation of IL-12/Pulse IL-2 in Adults with Advanced Solid Tumors

* 00-C-0105:
Phase I Trial and Pharmacokinetic Study of Temozolomide and O(6)-Benzylguanine in Childhood Solid Tumors

* 00-C-0092:
A Randomized Trial of Filgrastim-SD/01 vs. Filgrastim in Newly Diagnosed Children and Young Adults with Sarcoma Treated with Dose-Intensive Chemotherapy

* 00-C-0080:
A Double Blind Randomized Crossover Phase III Study of Oral Thalidomide versus Placebo in Patients with Stage D0 Androgen Dependent Prostate Cancer Following Limited Hormonal Ablation

* 00-C-0079:
Susceptibility to Breast Cancer

* 00-C-0078:
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples from Patients with Cancer

* 00-C-0074:
Evaluation of Late Effects and Natural History of Disease in Patients Treated with Radiotherapy

* 00-C-0070:
Phase I Trial and Pharmacokinetic Study of Arsenic Trioxide in Pediatric Patients with Refractory Leukemia or Lymphoma

* 00-C-0069:
Phase II Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) with Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-Fluorouracil for Peritoneal Carcinomatosis

* 00-C-0050:
Randomized Trial of Patient-Specific Vaccination with Conjugated Follicular Lymphoma-Derived Idiotype with Local GM-CSF in First Complete Remission

* 00-C-0030:
A Phase I/II Study of the Efficacy and Toxicity of Humanized Anti-Tac (Zenapax™ (Trademark)) in the Therapy of Tac-Expressing Adult T-Cell Leukemia

* 00-C-0019:
A Phase I Study of Isolated Lung Perfusion with Paclitaxel and Moderate Hyperthermia in Patients with Unresectable Pulmonary Malignancies

* 00-C-0018:
A Pilot Study of Proteomic Evaluation of Epithelial Ovarian Cancer Patients in First Clinical Remission: Development of a Protein Fingerprint Profile Associated with Relapse

* 00-AR-0222:
Studies of the Pathogenesis and Natural History of Arthritis and Related Conditions

* 99-N-0178:
Feasibility of Neuromuscular Stimulation for Laryngeal Elevation During Swallowing

* 99-N-0169:
Effect of the Humanized Monoclonal Antibody Against the Interleukin-2 Receptor Alpha Subunit (IL-2R-Alpha; Zenapax® (Registered Trademark)) on Inflammatory Activity in the CNS in MS in a Baseline-to-Treatment, Cross-Over, MRI-Controlled Single Cente

* 99-N-0122:
PET Imaging of Serotonin Receptors in Seizure Disorders

* 99-N-0045:
Study of Abnormal Acquired and Genetic Coagulation Factors in Children with Porencephaly and Stroke

* 99-N-0009:
Sensory Function in Idiopathic Voice Disorders

* 99-M-0172:
Integrating EEG/MEG and fMRI: Activity Correlation Between Frontal and Temporal Lobe Structures in Schizophrenic Patients, Their Siblings and Unrelated Normal Volunteers

* 99-M-0166:
Investigation of Brain Function During Eyeblink Responding in Normal Volunteers and Patients with Schizophrenia (A Study of Behavior and Evoked Potentials)

* 99-M-0073:
M2 Receptor Measurements in Aging and in Alzheimer's Disease

* 99-I-0149:
Analysis of the Occurrence of Perilesional Edema and Seizures in Patients With Inactive Cysticercosis

* 99-I-0015:
Immunologic and Virologic Characterization of HIV-Infected Patients After Cessation of Highly Active Antiretroviral Therapy (HAART)

* 99-HG-0130:
Microarray Analysis for Human Genetic Disease

* 99-H-0076:
Fiberoptic Bronchoscopy in Patients with Asthma

* 99-H-0069:
Pulmonary Fibrosis Associated with Rheumatoid Arthritis: Identification of Genetic Polymorphisms

* 99-H-0068:
Specimen Procurement for Individuals with Pulmonary Fibrosis Associated with Rheumatoid Arthritis

* 99-H-0064:
Exploratory Study of Non-Myeloablative Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusions for Metastatic Neoplasms Refractory to Standard Therapy

* 99-H-0056:
Pulmonary Fibrosis with Rheumatoid Arthritis: Definition of the Natural History of Disease

* 99-H-0050:
Non-myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients with Debilitating Hematologic Diseases

* 99-H-0048:
Technical Evaluation of Cardiovascular Magnetic Resonance Imaging and Spectroscopy

* 99-H-0037:
Apheresis of Family Members of Patients Undergoing Allogeneic Bone Marrow Transplantation. A Pre-Clinical Study of Selective Depletion of Donor Lymphocytes to Prevent Acute Graft-Versus-Host Disease

* 99-EI-0035:
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects with Nystagmus or Strabismus

* 99-DK-0120:
Screening Protocol for Patients Needing a Kidney, Kidney-Pancreas, or Islet Cell Transplant

* 99-DK-0119:
Monitoring for Donor-Specific Hyporesponsiveness Following Renal and Pancreatic Allotransplantation

* 99-DK-0107:
Live Donor Renal Donation for Allotransplantation

* 99-DK-0042:
Long-Term Therapy with Ribavirin for Chronic Hepatitis C

* 99-DK-0002:
Heart Disease Risk Factors in African Americans

* 99-D-0070:
Natural History of Salivary Gland Dysfunction and Sjogren's Syndrome

* 99-CH-0103:
Evaluation of Women With Endocrine and Reproductive-Related Conditions

* 99-CH-0055:
New Imaging Modalities in the Evaluation of Patients with Ectopic Cushing's Syndrome

* 99-CH-0012:
The Safety and Effectiveness of Surgery with or without Raloxifene (Evista™ (Trademark), Lilly) for the Treatment of Pelvic Pain Caused by Endometriosis

* 99-CC-0168:
Collection and Distribution of Blood Components from Healthy Donors for In Vitro Research Use

* 99-CC-0163:
Functional and Metabolic Imaging Using Magnetic Resonance at 3.0 and 1.5 Tesla

* 99-CC-0061:
Contrast Enhanced Resonance Angiography (MRA) in the Diagnosis of Atherosclerotic Disease: A Pilot Technical Development Study

* 99-C-0170:
A Phase II Study to Evaluate Radiofrequency Ablation of Renal Cancer

* 99-C-0158:
Treatment of Patients with Metastatic Melanoma Using Cloned Lymphocytes Following the Administration of a Non-Myeloablative but Lymphocyte Depleting Regimen

* 99-C-0142:
Phase II Trial of Individualized Mutant p53 Peptide-Pulsed Cultured Autologous Dendritic Cells in the Adjuvant Treatment of Patients with Locally Advanced Non-Small Cell Lung Cancer After Standard Therapy

* 99-C-0138:
Vaccine Therapy with Tumor Specific p53 Peptides in Adult Patients with Adenocarcinoma of the Breast or Ovary

* 99-C-0137:
Vaccine Therapy with Tumor Specific p53 Peptides in Adult Patients with Low Burden Adenocarcinoma of the Ovary

* 99-C-0134:
A Long-Term Observational Study of Immunologic Reconstitution in HIV-1 Infected Children who are Receiving Combination Protease Inhibitor and Reverse Transcriptase Inhibitors

* 99-C-0128:
Evaluation for NCI Surgery Branch Clinical Research Protocols

* 99-C-0127:
Phase I and Pharmacokinetic Study of UCN-01 and Fludarabine in Relapsed or Refractory Low-Grade Lymphoid Malignancies

* 99-C-0125:
Osteosarcoma: Outcome of Therapy Based on Histologic Response: A Collaborative Effort of the POB/NCI, Texas Children's Hospital and University of Oklahoma

* 99-C-0123:
A Phase II Study of Isolated Hepatic Perfusion (IHP) with Melphalan for Metastatic Unresectable Cancers of the Liver

* 99-C-0116:
A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning

* 99-C-0099:
Examination of Clinical and Laboratory Abnormalities in Patients with Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy

* 99-C-0025:
The Use of Radiofrequency Ablation to Treat Hepatic Neoplasms

* 99-C-0023:
A Phase I/II Trial of Vaccination with Mutant Ras Peptide-Pulsed Dendritic Cells in the Treatment of HLA A2.1 Positive Patients with Colorectal Cancer

* 99-AT-0033:
An Exploratory Study of the Effects of Oral Vitamin C Administration on Insulin Sensitivity and Vascular Reactivity in Subjects with Type 2 Diabetes

* 99-AR-0004:
Molecular Basis of Primary Immunodeficiencies

* 98-N-0065:
Stimulation of the Human Central and Peripheral Nervous System with a Magnetic Stimulator

* 98-N-0047:
Immuno-Virological Evaluation of Human T Cell Leukemia Virus Type-1 Associated Myelopathy (HAM/TSP)

* 98-I-0070:
Magnetic Resonance Imaging of the Face and Bones

* 98-I-0027:
The Characterization of CD34+ Derived Mast Cell Precursors Mobilized by Administration of Granulocyte Colony Stimulating Factor

* 98-H-0144:
Treatment of Diamond Blackfan Anemia with Antithymocyte Globulin and Cyclosporine A

* 98-H-0062:
Role of Exotoxins in the Pathogenesis of Pseudomonas Aeruginosa

* 98-EI-0085:
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects with Ocular Inflammatory or Immunologic Diseases

* 98-EI-0076:
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects with Retinovascular Diseases

* 98-EI-0072:
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects with Inherited Ophthalmic Diseases

* 98-D-0145:
Screening and Natural History of Patients with Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome

* 98-D-0116:
Spatial Organization of Viridans Streptococci in Oral Biofilms

* 98-CH-0111:
Safety and Efficacy of Orlistat (Xenical, Hoffmann LaRoche) in African American and Caucasian Children and Adolescents with Obesity-Related Comorbid Conditions

* 98-CH-0081:
Clinical and Basic Investigations into Smith-Lemli-Opitz Syndrome

* 98-CC-0090:
Evaluation of Hematologic Patients - Training Protocol

* 98-CC-0067:
Treatment of Acute Deep Vein Thrombosis of the Lower Extremity with Intraclot, Pulse-Sprayed Recombinant Tissue Plasminogen Activator, Plus Heparin and Warfarin: A Pilot Study

* 98-CC-0066:
Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan

* 98-CC-0019:
Normal Volunteer Scanning on MR

* 98-C-0163:
The Use of Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) to Assess the Effects of Anti-Neoplastic Therapy on Tumor Associated Vasculature

* 98-C-0138:
Evaluation of the Association of Polymorphisms in the Innate Immune System with the Risk for Blastomycosis Dermatitidis Infection in Patients not Infected with HIV and Complications Associated with Blastomycosis dermatitidis Infection

* 98-C-0137:
Evaluation of the Association of Polymorphisms in the Innate Immune System with the Risk for Cryptococcus neoformans Infection in Patients not Infected with HIV and Complications Associated with Cryptococcus neoformans Infection

* 98-C-0037:
Evaluation, Treatment, and Natural History of Children with Cancer

* 98-AA-0056:
Functional Neuroanatomy of Positive and Negative Affect in Alcoholics and Non-Alcoholics

* 98-AA-0009:
Screening Evaluation for NIAAA Protocols

* 97-N-0170:
The Nosology and Etiology of Leukodystrophies of Unknown Cause

* 97-N-0070:
Training Protocol for Various Sleep Disorders in Patients with Neurological Disorders

* 97-N-0049:
Tolerability and Primary Efficacy of CX516 in Alzheimer's Disease

* 97-M-0126:
Childhood Onset Psychotic Disorders: Characterization and Treatment with Atypical Neuroleptics

* 97-I-0191:
Studies of Lymphocyte Kinetics Using Stable Isotopes

* 97-I-0189:
Studies of Lymphocyte Kinetics Using Bromodeoxyuridine

* 97-I-0166:
Polymorphism of the Herpes Simplex Virus Receptor

* 97-I-0096:
Evaluation, Treatment, and Monitoring of Patients With Known or Suspected Parasitic Infection

* 97-HG-0078:
Genetic Analysis of Parkinson's Disease

* 97-H-0204:
Cardiovascular Magnetic Resonance Imaging

* 97-H-0196:
A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy

* 97-H-0154:
High-Dose Cyclophosphamide with CD34+ Selected Autologous Hematopoietic Cell Support for Treatment of Refractory Chronic Autoimmune Thrombocytopenia

* 97-H-0130:
Collection of Blood and Bone Marrow from Normal Volunteers and Patients for Research Purposes

* 97-H-0061:
Evaluation and Treatment of Pulmonary Patients not Participating in Research (Training Protocol)

* 97-H-0041:
Screening Protocol for Subjects Being Evaluated for Hematology Branch Protocols

* 97-H-0026:
Magnetic Resonance at 1.5 and 3 Tesla

* 97-H-0022:
Segmental Bronchoalveolar Lavage

* 97-DC-0180:
Genetic Analysis of Human Hereditary Hearing Impairment

* 97-DC-0057:
Non-Parametric and Parametric Linkage Studies of Stuttering

* 97-D-0163:
Diagnosis and Evaluation of Patients in Need of Third Molar Removal or Suffering from Chronic Facial Pain

* 97-D-0055:
Studies on Tissues from Patients with Fibrous Dysplasia of Bone/McCune Albright Syndrome and Other Disorders of Calcified Tissues

* 97-CH-0076:
Tumors of the Pituitary Gland and Associated Conditions: A Genetic Investigation

* 97-CH-0064:
Evaluation and Intervention for Ambulation, Growth, and Basilar Invagination in Osteogenesis Imperfecta

* 97-C-0178:
Fludarabine Treatment of Chronic Lymphocytic Leukemia: c-DNA Microarray Gene Expression Analysis, and Pre-Clinical Bone Marrow Transplant/Immunotherapy Studies

* 97-C-0147:
Collection of Serum and Tissue Samples from Patients with Biopsy-Proved or Suspected Malignant Disease

* 97-C-0143:
Investigation of the Human Immune Response in Normal Subjects and Patients with Disorders of the Immune System and Cancer

* 97-C-0129:
Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification System

* 97-C-0110:
Phase I/II Study of Tac-Expressing Malignancies Other than Adult T-Cell Leukemia (ATL) with Yttrium-90 Radiolabeled Humanized Anti-Tac and Calcium-DTPA

* 97-C-0093:
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients with Primary and Metastatic Brain Tumors

* 97-C-0052:
A Pilot Study of Autologous T-Cell Transplantation with Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

* 97-C-0040:
EPOCH Chemotherapy Plus Rituximab for Previously Treated Patients with AIDS-Associated Lymphoma

* 97-C-0028:
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers

* 97-C-0019:
Phase I/II Study in Patients with Metastatic Melanoma of Immunization with Dendritic Cells Presenting Epitopes Derived from the Melanoma Associated Antigen MART-1 and gp100

* 97-AT-0105:
Methods for Assessing Insulin Sensitivity In Vivo

* 96-N-0089:
Characteristics of Idiopathic Familial Voice Disorders

* 96-N-0088:
Characteristics of Idiopathic Familial Speech Disorders

* 96-N-0009:
Diagnosis and Natural History Protocol for Patients with Neurological Conditions

* 96-M-0124:
Genetics of Obsessive-Compulsive Disorder: A Collaborative Study

* 96-I-0052:
A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients with Suspected Chronic Lyme Infection and Selected Control Populations

* 96-H-0100:
Role of Genetic Factors in the Pathogenesis of Lung Disease

* 96-H-0049:
Use of Granulocyte Colony Stimulating Factor (G-CSF) Mobilized Leukapheresis Collections from Normal Volunteers to Develop Improved Methods of Stem Cell and Lymphocyte Selection for Allogeneic Transplantation

* 96-D-0095:
Evaluation of a TNF-alpha Modulator for the Treatment of Oral Lesions in HIV/AIDS Patients

* 96-CH-0101:
Population Differences in the Insulin Sensitivity, Resting Energy Expenditure, and Body Composition of Overweight Children and Children of Overweight Parents

* 96-CH-0033:
An Open, Randomized, Long-Term Clinical Trial of Flutamide, Testolactone, and Reduced Hydrocortisone Dose vs. Conventional Treatment of Children with Congenital Adrenal Hyperplasia

* 96-C-0104:
A Pilot Study of Paclitaxel/Cyclophosphamide and High Dose Melphalan/Etoposide with Autologous Progenitor Cell Transplantation for the Treatment of Inflammatory Breast Cancer

* 96-C-0102:
Evaluation and Treatment of Patients with Dermatologic Diseases

* 96-C-0097:
The Acquisition of Blood and Skin Samples from Patient Volunteers to Support Research Activities on Dermatologic Diseases

* 96-C-0071:
Follow-up Protocol for Patients in the Center for Cancer Research

* 95-N-0121:
The Natural History and Pathogenesis of Fabry Disease

* 95-M-0150:
A Neurobiological Investigation of Patients with Schizophrenia Spectrum Disorders and Their Siblings

* 95-M-0097:
An Endocrine Model For Postpartum Mood Disorders

* 95-M-0096:
The Evaluation and Follow-up of Patients with Memory Disorder and Normal Controls

* 95-I-0027:
Virologic and Immunologic Evaluation of Lymph Node, Tonsillar, and Rectal Biopsies

* 95-HG-0193:
Clinical and Basic Investigations into Hermansky-Pudlak Syndrome

* 95-HG-0165:
Outcomes of Education and Counseling for HNPCC Testing

* 95-HG-0158:
Genetic Analysis of Hereditary Prostate Cancer

* 95-HG-0066:
Genetic Analysis of Immune Disorders

* 95-H-0186:
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)

* 95-H-0167:
Effect of Hypoxia and Smoking on Oxidation of Proteins and Nucleic Acids in Human Volunteers

* 95-H-0047:
Evaluation of Patients with Heart Disease Not Eligible for Research Protocols

* 95-CH-0110:
Endometrial Mediators of Gonadal Steroid Action

* 95-CH-0059:
Definition of the Genotype and Clinical Phenotype of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and its Associated Conditions (Carney Complex)

* 95-CC-0123:
Evaluation of Healthy Volunteer Marrow Donors Participating in the National Marrow Donor Program (NMDP)

* 95-AR-0082:
Studies of the Pathogenesis and Natural History of Psoriatic Arthritis

* 94-M-0121:
Bone Mineral Density in Patients with Major Depression with Melancholic and Atypical Features: Relation to Stress-System Neurohormonal Function

* 94-I-0203:
Cytokine Expression in Allergic Asthma

* 94-I-0079:
Eosinophil Activation and Function in Parasitic Infections and Other Conditions with Increased Tissue or Peripheral Blood Eosinophilia in Humans

* 94-I-0073:
Recruitment of Peripheral Blood Hematopoietic Progenitors by Granulocyte Colony Stimulating Factor (GCSF)

* 94-HG-0193:
Clinical and Genetic Studies of Limb Anomaly Syndromes

* 94-HG-0132:
Etiology of Sporadic Multiple Congenital Anomaly Syndromes

* 94-H-0010:
Evaluation, Treatment and Training Protocol for Patients with Bone Marrow Failure States, Isolated or Multilineage Cytopenias, Metastatic Solid Tumors, or Hematologic Malignancies

* 94-E-0165:
Studies in the Natural History and Pathogenesis of Childhood Idiopathic Inflammatory Myopathies

* 94-DK-0195:
Use of Hypocalcemic Intraarterial Infusion Into the Thyroid/Parathyroid Bed to Localize Occult Parathyroid Adenomas

* 94-DK-0133:
Genetic Markers for Focal Segmental Glomerulosclerosis

* 94-DK-0127:
Pathogenesis of Focal Segmental Glomerulosclerosis

* 94-D-0188:
Bone Regeneration Using Marrow Stromal Cells

* 94-D-0018:
Salivary Evaluation in Normal Volunteers

* 94-CC-0130:
Rehabilitation Medicine Screening Protocol

* 94-C-0074:
Treatment and Natural History Study of Lymphomatoid Granulomatosis

* 94-AR-0105:
Genetics and Pathophysiology of Familial Mediterranean Fever and Related Disorders

* 94-AR-0066:
Studies of the Pathogenesis and Natural History of Systemic Lupus Erythematosus (SLE)

* 94-AA-0124:
Eye Movements in Alcoholics, Patients with Psychiatric or Neurological Disorders, and Normal Controls

* 93-N-0202:
Diagnosis and Natural History Protocol for Patients with Different Neurological Conditions

* 93-N-0151:
Evaluation and Treatment of Patients with Spinal Vascular Abnormalities

* 93-M-0170:
Regional Cerebral Blood Flow Studies of Object Perception, Identification, Localization, and Memory

* 93-M-0122:
A Trial of Prophylaxis for the PANDAS Subgroup

* 93-I-0119:
Detection and Characterization of Host Defense Defects

* 93-I-0106:
Cryptococcosis in Previously Normal Adults

* 93-I-0063:
Study of the Immunopathogenesis, Natural History, and Genetics of Autoimmune Lymphoproliferative Syndrome (ALPS) Associated with an Expansion of CD4-8-/TCR alpha/beta+ T Cells and Defective Lymphocyte Apoptosis

* 93-I-0057:
Apheresis Procedures to Obtain Plasma or Leukocytes for In Vitro Studies

* 93-DK-0127:
Family Studies in Metabolic Diseases and Mineral Metabolism

* 93-CH-0054:
The Relative Effects of Androgen, Estrogen, and the Combination of Androgen and Estrogen on Growth Rate, GH Binding Protein, IGF-I, and Cognitive Function in Growth Hormone-Treated Girls with Turner Syndrome

* 93-C-0133:
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

* 92-N-0226:
Establishing the Physiology of Syringomyelia

* 92-M-0262:
Neuropsychiatric Evaluation of Normal Subjects and Psychiatric and Neurologic Contrast Groups

* 92-M-0174:
The Central Nervous System Effects of Pharmacologically Induced Hypogonadotropic Hypogonadism with and without Estrogen and Progesterone Replacement

* 92-I-0125:
Analysis of Peripheral Blood Versus Lymphoid Tissue in HIV-Infected Individuals and Normal Patients

* 92-H-0189:
Evaluation of Patients with Known or Suspected Heart Disease (Screening Protocol)

* 92-EI-0113:
Immunopathology of Ocular Diseases in Humans

* 92-DK-0156:
Studies of Immunologically-Mediated Kidney Diseases

* 92-DK-0033:
Pharmacokinetics and Biodistribution of Ascorbic Acid in Healthy Human Subjects

* 92-DC-0178:
Functional Neuroimaging Studies of Speech Motor Control and Language Processing

* 92-D-0243:
Somatosensory Studies of Pain and Pain Control Measured with Oxygen-15 Water Positron Emission Tomography and Functional MRI in Normals and Patients with Neuropathic or Chronic Pain Conditions

* 92-CH-0223:
Autoimmune Premature Ovarian Failure: A Controlled Trial of Alternate-Day Prednisone Therapy

* 92-CH-0034:
Growth Hormone Therapy in Osteogenesis Imperfecta

* 92-CH-0011:
Treatment of Hypoparathyroidism with Synthetic Human Parathyroid Hormone 1-34

* 92-CC-0141:
The Cardiopulmonary Effects of Endotoxin in Normal Human Volunteers

* 92-C-0137:
A Trial of Carboxypeptidase-G2 (CPDG2) for the Management of Patients with Intrathecal Methotrexate Overdose

* 92-C-0094:
Continuing Care and Treatment for Patients in the Center for Cancer Research

* 92-C-0078:
Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens

* 91-N-0225:
Clinical and Biochemical Effects of Macrophage-Targeted Glucocerebrosidase on Neurological Involvement in Neuronopathic Gaucher's Disease

* 91-M-0230:
Mechanisms of Individual Variation of Dextroamphetamine Effects in Normal Human Subjects

* 91-M-0124:
Structural and Functional Imaging of Neuropsychiatric Patients and Normal Volunteers with 1.5 Tesla MRI

* 91-I-0140:
Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Reproductive Fluids in HIV-Infected and HIV-Uninfected Volunteers

* 91-DK-0085:
Studies of Hyperparathyroidism and Related Disorders

* 91-DK-0066:
Fasting Hypoglycemia: Diagnosis and Treatment

* 91-CH-0127:
Ovarian Follicle Function in Patients with Premature Ovarian Failure

* 91-CC-0117:
Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection in a Blood Donor Population

* 91-AR-0196:
Studies on the Natural History and Pathogenesis of Polymyositis, Dermatomyositis, and Related Diseases

* 90-N-0149:
Early Copper Histidine Therapy in Menkes Disease: Relationship of Molecular Defects to Neurodevelopmental Outcomes

* 90-M-0142:
Brain Procurement for the Neuropathology Section, CBDB

* 90-M-0088:
The Treatment of Menstrually-Related Mood Disorders with the Gonadotropin Releasing Hormone (GnRH) Agonist, Depot Leuprolide Acetate (Lupron)

* 90-M-0014:
Studies of Frontal Lobe Function During Cognitive Stimulation as Measured with Oxygen-15 Water Positron Emission Tomography in Normal Subjects and Neuropsychiatric Patients

* 90-DK-0137:
Evaluation of the Gastrinoma in Patients with Zollinger-Ellison Syndrome

* 90-CC-0168:
A Rigid Body Data Base on Human Movement

* 89-N-0045:
Evaluation of Progression in Multiple Sclerosis by Magnetic Resonance Imaging (MRI)

* 89-M-0160:
Inpatient Evaluation of Neuropsychiatric Patients

* 89-M-0006:
Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Controls

* 89-I-0174:
Study of Patients with Known or Suspected Infection with Strongyloides Stercoralis

* 89-I-0158:
Studies of Immune Regulation in Patients with Common Variable Immunodeficiency and Related Humoral Immunodeficiency Syndromes

* 89-I-0035:
Effects of Infection with the Human Immunodeficiency Virus on the Development and Function of Bone Marrow Cells

* 89-DK-0173:
Studies of States with Resistance to Vitamin D and Parathyroid Hormone

* 89-DK-0152:
Determination of Glomerular Filtration Rate, Effective Renal Plasma Flow and Glomerular Capillary Wall Permselectivity

* 89-DK-0015:
Medical Therapy of Zollinger-Ellison Syndrome

* 89-C-0086:
Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders

* 88-M-0131:
A Screening Protocol to Evaluate Women with Perimenopause-Related Mood and Behavioral Disorders

* 88-I-0083:
Host Response to Infection and Treatment in the Filarial Diseases of Humans

* 88-DK-0194:
Evaluation of Treatment with Interferon, Octreotide, or their Combination in Patients with Zollinger-Ellison Syndrome and Progressive Metastatic Non-B Islet Cell Neoplasm

* 87-DK-0029:
Diagnosis and Treatment of Patients with Cystic Fibrosis and Other Disorders of the Respiratory System or Pancreas

* 87-CC-0160:
Comparison of Ultrasound and Videofluoroscopic Imaging Techniques in Diagnosing Oropharyngeal Dysphagia in Neurologically Impaired Subjects

* 87-CC-0091:
Nuclear Magnetic Resonance Imaging/Spectroscopy at 1.5 and 3.0 Tesla

* 86-M-0096:
Studies of Genetic Heterogeneity in Patients with Lysosomal Storage Disorders

* 86-H-0088:
Lymphocytapheresis of Patients with Pancytopenia

* 86-EI-0062:
Trial of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis

* 85-N-0195:
A Training Protocol for the use of Botulinum Toxin in the Treatment of Neurological Disorders

* 85-M-0115:
Biological Markers in Childhood Psychiatric Disorders

* 85-I-0127:
Treatment of Patients with Cysticercosis with Praziquantel or Albendazole

* 85-H-0105:
Cardiovascular Evaluation of Patients with Familial Hypercholesterolemia and Normal Individuals

* 85-DK-0082:
Acromegaly Treatment and Natural History

* 84-M-0050:
Biochemical, Physiological, and Psychological Measures in Normal Controls and Relatives of Psychiatric Patients

* 84-D-0056:
Evaluation and Treatment of Salivary Gland Dysfunction

* 84-CH-0169:
Endocrine Studies of Healthy Children

* 83-M-0176:
Neuropsychological Evaluation of Psychiatric and Neurological Patients

* 83-DK-0018:
The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients with Hypersecretion of Gastric Acid

* 83-C-0022:
Psychological Benefits of a Normalized Camping Experience for Children with Cancer and HIV Infection

* 82-I-0183:
Studies of Immune Regulation in Patients with Ulcerative Colitis, Crohn's Disease, or Unclassified Inflammatory Bowel Diseases

* 82-H-0032:
Comprehensive Evaluation of the Etiology and Pathogenesis of Chronic Lung Disease (Screening Protocol)

* 82-CH-0045:
Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients with Adrenal Insufficiency

* 81-N-0010:
Regional Cerebral Utilization of Glucose in Patients with a Diagnosis of Frontal Lobe Dementia, Atypical Parkinsonian Disorder, and Other Basal Ganglia Disorders

* 81-M-0126:
The Phenomenology and Biophysiology of Menstrually Regulated Mood and Behavioral Disorders

* 80-M-0083:
Bipolar Genetics: A Collaborative Study

* 80-EI-0093:
Visual Motor Coordination in Man

* 79-H-0100:
Teaching Protocol for the Evaluation of Plasma Lipoproteins

* 79-CC-0101:
Exploration of the Diagnostic Capabilities of Ultrasound of the Oropharynx and Larynx

* 78-C-0039:
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer

* 77-I-0094:
Study of Patients with Parasitic Infections of the Gastrointestinal Tract

* 77-DK-0096:
Studies on Thyroid Nodules and Thyroid Cancer

* 77-DK-0002:
Evaluation of Patients with Thyroid Function Disorders

* 76-N-0021:
Combined Clinical, Immunological and Virological Assessment of Patients with Multiple Sclerosis (MS)

* 76-H-0051:
Lipoprotein Metabolism in Normal Volunteers and Hyperlipoproteinemic Patients

* 76-DK-0081:
Studies with 1,25-Dihydroxycholecalciferol

* 76-DK-0006:
Studies of Molecular Genetics of Insulin Secretion, Insulin Action, and Diabetes Mellitus

Active Followup, Protocols NOT Recruiting New Patients 

* 04-I-0028:
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiple Strain Ebola DNA Plasmid Vaccine, VRC-EBODNA012-00-VP, in Adult Volunteers

* 04-H-0154:
Atherosclerosis in the Coronary and Carotid Arteries: Correlations between Coronary IVUS, Carotid Ultrasound, and Carotid MRI

* 04-EI-0223:
Efficacy of Elevated CD4 Cell Counts on CMV Retinitis

* 04-EI-0013:
Pilot Study of Intravitreal Injection of Triamcinolone Acetonide Formulation for Retinal Vascular Disorders

* 04-C-0155:
Barrett's Esophagus Early Detection Study

* 03-N-0314:
Clinical Laboratory Evaluation of Chronic Orthostatic Intolerance

* 03-N-0286:
Study of Weekly Dosing Regimens of Replagal in Patients with Fabry Disease with Incomplete Clinical Response to Long-Term Therapy

* 03-N-0199:
Relationship of Autonomic Function to Hypnotic Susceptibility

* 03-N-0182:
Propranolol for Syncope with Sympathoadrenal Imbalance

* 03-N-0008:
The Effect of Peripheral Homotopic and Heterotopic Stimulation on Cortical Excitability

* 03-I-0087:
A Phase I/II Clinical Trial of Modified Vaccinia Virus Ankara (MVA) to Evaluate its Safety, Immunogenicity and Protective Efficacy Against Dryvax® (Registered Trademark) Challenge in Vaccinia-Immune Individuals

* 03-I-0022:
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA009-00-VP, in Uninfected Adult Volunteers

* 03-H-0219:
A Genome-Wide Scan for Quantitative Trait Loci of Hematocrit - A Framingham Study

* 03-H-0192:
Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-back for Hematological Malignancies - Effect of Irradiated Donor Lymphocytes on Chimerism

* 03-EI-0291:
A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema

* 03-EI-0101:
Pilot Study of Intravitreal Injection of EYE001 (Anti-VEGF Pegylated Aptamer) for Advanced Ocular Disease of Von Hippel-Lindau (VHL) Disease

* 03-CC-0046:
A Study of Daclizumab in Chronic Immune Thrombocytopenia (ITP)

* 03-C-0229:
Phase I-II Study of the Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children with Neutropenia

* 03-C-0157:
A Phase II Study of Perifosine in Patients with Metastatic Androgen Independent Prostate Cancer

* 03-C-0137:
Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion and Melphalan with or without Tumor Necrosis Factor in the Patient with Localized, Advanced, Extremity Melanoma

* 02-N-0115:
Donepezil for Dementia in Parkinson's Disease: A Randomized, Double Blinded Placebo Controlled Crossover Trial

* 02-N-0010:
EEG Study of Movement-Related Center-Surround Organization in Hand Dystonia

* 02-M-0254:
A Phase 2A Study of Soy Isoflavones in the Treatment of Major Depression

* 02-I-0316:
A Phase I/II Clinical Trial of Modified Vaccinia Virus Ankara (MVA) to Evaluate its Safety, Dosing Schedule, Immunogenicity and Protective Efficacy Against Dryvax Challenge in Vaccinia-Naive Individuals

* 02-I-0213:
A Randomized Trial Examining the Use of Daclizumab in Wegener's Granulomatosis

* 02-H-0264:
Stem Cell Mobilization as Therapy for Chronic Myocardial Ischemia in Patients with Coronary Artery Disease

* 02-EI-0257:
Multi-Center Randomized Phase I/II Trial to Study the Effects of Cyclooxygenase-2 Inhibition on the response to Photodynamic Therapy in Patients with Age-Related Macular Degeneration

* 02-EI-0242:
Evaluation of Subcutaneous Daclizumab Treatments in Patients with Non-infectious Sight-threatening Uveitis: A Multicenter, Open-Label, Phase II Study

* 02-DK-0235:
Sirolimus for Focal Segmental Glomerulosclerosis

* 02-D-0274:
Static Magnets In The Treatment of Sciatica

* 02-CH-0100:
Supplemental Calcium in Overweight Out-Patients

* 02-C-0218:
A Pilot Trial of Pox Vector PSA Vaccine With Concurrent Docetaxel Vs. Pox Vector PSA Vaccine Followed By Docetaxel In Metastatic Androgen Independent Prostate Cancer

* 02-C-0145:
A Phase I Trial of a Thalidomide Analog, CC-5013, for the Treatment of Patients with Recurrent High-Grade Gliomas

* 02-C-0106:
An Open-Label Study of MDX-CTLA4 in Combination with gp100 Peptides Emulsified with Montanide ISA 51 in the Treatment of Patients with Stage IV Melanoma

* 02-C-0009:
A Phase I Dose Escalation Study of B-Lymphocyte Stimulator (BLyS) Administered Subcutaneously in Patients with Selective IgA Deficiency

* 02-C-0006:
A Phase I Study of Tenofovir Disoproxil Fumarate (PMPA Prodrug), A Novel Nucleotide Analog Reverse Transcriptase Inhibitor in Children with HIV Infection

* 01-N-0118:
Effect of Antiglutamatergic Treatment in Parkinson's Disease

* 01-I-0239:
Studies of the Addition of Adefovir Dipivoxil to Lamivudine for the Treatment of Chronic Hepatitis B: A Randomized, Double-Blind, Placebo Controlled Study in HIV-Infected Patients and an Open-Label Study in HIV-Negative Subjects

* 01-I-0126:
A Phase III Multicenter Randomized Study of the Biological and Clinical Efficacy of Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients with Low CD4+ Counts Under Active Antiretroviral Therapy (SILCAAT Amendment 4)

* 01-I-0079:
Evaluation of an HIV-1 DNA Vaccine Encoding a Modified Gag-Pol Protein in Uninfected Adult Volunteers

* 01-H-0031:
National Heart, Lung, and Blood Institute Data Distribution

* 01-EI-0208:
Feasibility Study of the Identification and Treatment of Feeder-Vessels of Choroidal Neovascularization in Age-Related Macular Degeneration

* 01-DK-0036:
Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression

* 01-D-0197:
A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome

* 01-D-0105:
Topiramate in the Treatment of Sciatica

* 01-C-0256:
Phase I Trial of 2-Methoxyestradiol (2ME2), (NSC-659853) an Angiogenesis Inhibitor, in Patients with Solid Tumors

* 01-C-0236:
Follow-Up of a Phase-I Gene Therapy Trial of Patients with Leukocyte Adherence Deficiency

* 01-C-0073:
The Seroprevalence of Kaposi's Sarcoma Herpesvirus in the United States

* 01-C-0027:
Natural History of Plexiform Neurofibromatosis Type I

* 00-I-0163:
Persistence of Epstein-Barr Virus in Vivo

* 00-I-0071:
A Randomized, Open-Label, Phase III, International Study of Recombinant IL-2 (Proleukin) in Patients with HIV-1 Infection and CD4 Cell Counts Greater than or Equal to 300 Cells/mm3: Evaluation of Subcutaneous Proleukin in a Randomized International Tria

* 00-I-0020:
Immunologic and Virologic Studies of Intermittent Versus Continuous HAART in the Treatment of HIV Disease

* 00-H-0169:
A Phase II Study of Antithymocyte Globulin (ATG) and Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)

* 00-H-0032:
Treatment of Severe Aplastic Anemia with Combined Immunosuppression: Antithymocyte Globulin (ATG) and Cyclosporine A (CSA), and Mycophenolate Mofetil (MMF)

* 00-H-0025:
MRI Evaluation of Chest Pain Compatible with Myocardial Ischemia

* 00-DK-0196:
Sirolimus Monotherapy to Optimize Activation Induced Cell Death (AICD) in Renal Transplants Following Lymphocyte Depletion Induction with Thymoglobulin

* 00-DK-0186:
The Hep C Antiviral Long-Term Tx Against Cirrhosis (HALT-C) Trial: A Randomized Controlled Trial to Evaluate the Safety & Efficacy of Long-Term Peginterferon Alpha2A for Tx of Chronic Hep C in Patients Who Failed to Respond to Previous Interferon Therap

* 00-DK-0100:
Pulse Dexamethasone in Focal Segmental Glomerulosclerosis

* 00-DK-0013:
Tolerance Induction Following Human Renal Transplantation Using Treatment with a Humanized Monoclonal Antibody Against CD52 (Campath-1H)

* 00-C-0224:
A Phase I Clinical Trial of BMS-247550 (NSC 710428), an Epothilone B Analog, in Patients with Refractory Neoplasms

* 00-C-0216:
Randomized Comparison of Three Schedules of Peptide Immunization in Patients at High Risk for Recurrence of Melanoma

* 00-C-0149:
A Pilot Trial of Sequential Primary (Neoadjuvant) Combination Chemotherapy with Docetaxel/Capecitabine (TX) and Doxorubicin/Cyclophosphamide (AC) in Primary Breast Cancer with Evaluation of Chemotherapy Effects on Gene Expression

* 00-C-0137:
A Randomized Phase II Study of Either Immunotherapy w/a Regimen of Recombinant Pox Viruses that Express PSA/B7.1 + Adjuvant GM-CSF & IL-2 or Hormone Tx with Nilutamide in Patients w/Hormone Refractory Prostate Ca and No Radiographic Evidence of Disease

* 00-C-0133:
Pilot Study of Idiotype Vaccine and EPOCH-Rituximab Chemotherapy in Untreated Mantle Cell Lymphoma

* 00-C-0119:
Allogeneic Breast Protocol 1: T-Cell Depleted Allogeneic Blood Stem Cell Transplantation Using an Immunoablative Conditioning Regimen in Metastatic Breast Cancer

* 00-C-0094:
Mapping the Genetic Component of Hand-Use Preference

* 00-AR-0220:
Randomized Double Blind Active Treatment Controlled Trial of the Anti-TNF-Alpha Antibody Infliximab in Patients with Erosive Rheumatoid Arthritis

* 99-I-0106:
Trial of Varicella Vaccine for the Prevention of Herpes Zoster and Its Complications

* 99-I-0040:
Phase I/II Trial of TNFR:Fc (Etanercept) in Patients with Wegener's Granulomatosis

* 99-H-0140:
A Clinical Trial of TNFR:Fc in a Segmental Allergen Challenge Model of Asthma

* 99-H-0046:
Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T-Cell Add-Back for Hematological Malignancies - Role of Cyclosporine

* 99-D-0003:
Evaluation and Treatment to Improve Bone Quality and Prevent Fractures by the Percutaneous Replacement of Diseased Tissue in Polyostotic Fibrous Dysplasia and McCune Albright Syndrome

* 99-CC-0013:
Sonographic Evaluation of the Effects of Raloxifene on the Uterus and Ovaries in Premenopausal Patients at High Risk for Developing Breast Cancer

* 99-C-0143:
Pilot Study of Donor Th2 Cells for the Prevention of Graft-Versus-Host Disease in the Setting of Non-myeloablative, HLA-matched Allogeneic Peripheral Blood Stem Cell Transplantation

* 99-C-0088:
(1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who Receive Neurotoxic Therapy

* 99-C-0081:
Methods in Education for Breast Cancer Genetics

* 99-C-0053:
Von Hippel-Lindau Disease Genetic Epidemiology Study

* 99-C-0044:
Immunization of Patients with Metastatic Melanoma Using a Recombinant RF-GP100P209 Virus Encoding a gp100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence

* 99-C-0026:
A Prospective Study to Evaluate Potential Factors Affecting Weight Among Breast Cancer Patients Receiving Adjuvant Chemotherapy

* 99-C-0014:
Phase I Study of BL22, a Recombinant Immunotoxin for Treatment of CD22+ Leukemias and Lymphomas

* 98-I-0104:
Low Intensity Preparative Regimen Followed by HLA-Matched, Mobilized Peripheral Blood Stem Cell Transplantation for Chronic Granulomatous Disease

* 98-D-0146:
A Randomized, Placebo-Controlled Trial of Alendronate in the Treatment of Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome

* 98-C-0159:
Treatment of Patients with Metastatic Renal Cell Carcinoma with Neutralizing Antibody to Vascular Endothelial Growth Factor (VEGF)

* 98-C-0139:
Vaccine Therapy with Tumor Specific Mutated VHL Peptides in Adult Cancer Patients with Renal Cell Carcinoma

* 98-C-0123:
A Phase II Trial of Raloxifene in Pre-Menopausal Women at High Risk for Developing Invasive Breast Cancer

* 98-AR-0124:
Genetics of Rheumatoid Arthritis: The North American Rheumatoid Arthritis Consortium

* 97-I-0082:
Use of Combination Antiviral Therapy to Delineate the Identity and Longevity of Persistent Reservoirs of HIV-1 Infection and Replication

* 97-HG-0173:
Gene Analysis in Parkinson's Disease

* 97-H-0202:
Low Intensity Preparative Regimen Followed by HLA-Matched, Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in Older Adults

* 97-H-0117:
A Randomized Trial of Antithymocyte Globulin and Cyclosporine versus Cyclophosphamide and Cyclosporine in the Treatment of Severe Aplastic Anemia

* 97-H-0099:
HLA-Matched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies

* 97-DC-0044:
A Pilot Study of Immunoregulatory Factor Expression and Immune Responses in Patients with Squamous Cell Carcinoma or Papilloma of the Upper Aerodigestive Tract

* 97-DC-0002:
Genetic Linkage Analysis in Developmental Stuttering: Gene Mapping in Extended Kindreds and Candidate Gene Analyses

* 97-C-0141:
Vaccine Therapy with Tumor Specific Mutated RAS Peptides and IL-2 or GM-CSF for Adult Patients with Solid Tumors

* 97-C-0077:
Vaccination of Follicular Lymphomas with Tumor-Derived Immunoglobulin Idiotype

* 97-C-0050:
A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 with or without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas

* 97-C-0033:
Evaluation of Cellular and Humoral Immunity Against the Idiotype in Multiple Myeloma Patients Undergoing Autologous Transplantation After Idiotype Vaccination in an Attempt to Decrease the Risk of Relapse

* 97-C-0030:
Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation

* 96-M-0086:
Evaluation of rTMS in the Treatment of Mood Disorders

* 96-EI-0096:
Trial of Treatment of Non-Infectious Intermediate and Posterior Uveitis with Humanized Anti-Tac Antibody Therapy

* 96-C-0133:
Active Specific Immunotherapy for Follicular Lymphomas with Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines

* 95-I-0134:
Gene Therapy Approach for Chronic Granulomatous Disease

* 95-DK-0199:
Lamivudine for Chronic Hepatitis B

* 95-CH-0104:
Internal Jugular Vein Sampling for ACTH Levels for the Differential Diagnosis of Cushing Syndrome

* 95-C-0154:
Vaccine Therapy and Detection of Immunologic Responses with Human Papillomavirus 16 E6 and E7 Peptides in Patients with Metastatic or Locally Advanced Cervical Cancer and Other Cancers Carrying the HPV

* 95-C-0055:
A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin with G-CSF for Patients with Newly Diagnosed Advanced Stage Ovarian Cancer

* 95-C-0015:
A Phase I Study of the Combination of Continuous Daily CAI and Intermittent Paclitaxel in Adult Patients with Refractory Cancers or Lymphoma

* 94-N-0186:
Positron Emission Tomographic (PET) Scanning of Sympathetic Innervation and Function in Patients with Neurocardiologic Disorders

* 94-H-0033:
Retroviral Mediated Gene Transfer of the Fanconi Anemia Complementation Group C Gene to Hematopoietic Progenitors of Group C Patients

* 94-H-0001:
Obstructive Hypertrophic Cardiomyopathy (HCM) in Children: Natural History and Results of Dual Chamber (DDD) Pacemaker Therapy

* 94-C-0096:
Adjuvant Vaccine Therapy with Tumor Specific Mutated Ras Peptides in Patients with Colon or Pancreatic Cancers

* 92-N-0246:
Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction with the Thymidine Kinase Gene and Intravenous Ganciclovir

* 92-M-0132:
Treatment of Sydenham Chorea with Plasma Exchange or Prednisone

* 92-EI-0250:
Age-Related Eye Disease Study - Phase II

* 90-I-0120:
Comparison of Inflammatory Responses in Normal Volunteers and Patients with Abnormal Phagocyte Function Using the Suction Blister Technique

* 85-H-0087:
Clinical Course of Patients with Transfusional Hemochromatosis on Deferoxamine

* 84-H-0029:
Effect of Hydroxyurea on Fetal Hemoglobin Synthesis in Patients with Sickle Cell Anemia

* 79-N-0089:
Evaluation of Biological, Immunological and Therapeutic Parameters in Brain Tumor Patients

* 79-M-0123:
Affective Disorders and Affective Development: A Study of Child Rearing and Child Development in Normal Families and Families with Affective Disorders

* 79-C-0111:
The Treatment of Stage I and II Carcinoma of the Breast with Mastectomy and Axillary Dissection vs. Excisional Biopsy, Axillary Dissection, and Definitive Irradiation

Search The Studies | Help | Questions |
Clinical Center Home | NIH Home


Warren Grant Magnuson Clinical Center (CC)
National Institutes of Health (NIH)
Bethesda, Maryland 20892. Last update: 10/14/2004